[go: up one dir, main page]

CN111559965A - Substituted benzoyl compounds and application thereof in agriculture - Google Patents

Substituted benzoyl compounds and application thereof in agriculture Download PDF

Info

Publication number
CN111559965A
CN111559965A CN202010007574.7A CN202010007574A CN111559965A CN 111559965 A CN111559965 A CN 111559965A CN 202010007574 A CN202010007574 A CN 202010007574A CN 111559965 A CN111559965 A CN 111559965A
Authority
CN
China
Prior art keywords
radical
alkyl
compound
halo
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010007574.7A
Other languages
Chinese (zh)
Other versions
CN111559965B (en
Inventor
李义涛
林健
康维明
张虎
刘鹏飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dongguan Hec Pesticides R&d Co ltd
Original Assignee
Dongguan Hec Pesticides R&d Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dongguan Hec Pesticides R&d Co ltd filed Critical Dongguan Hec Pesticides R&d Co ltd
Publication of CN111559965A publication Critical patent/CN111559965A/en
Application granted granted Critical
Publication of CN111559965B publication Critical patent/CN111559965B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/16Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds containing nitrogen-to-oxygen bonds
    • A01N33/18Nitro compounds
    • A01N33/20Nitro compounds containing oxygen or sulfur attached to the carbon skeleton containing the nitro group
    • A01N33/22Nitro compounds containing oxygen or sulfur attached to the carbon skeleton containing the nitro group having at least one oxygen or sulfur atom and at least one nitro group directly attached to the same aromatic ring system
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/561,2-Diazoles; Hydrogenated 1,2-diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/36Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/44Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing eight carbon atoms

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dentistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明提供一种取代的苯甲酰类化合物及其在农业中的应用;具体地,本发明提供式(I)所示的化合物及其制备方法;含有这些化合物的组合物和制剂及其作为除草剂的用途;其中Q为氧代环己烯基或取代的吡唑基;R1、R2、R3、R4和R5各自独立地为氢、卤素、氰基、羟基等。

Figure DDA0002355877150000011
The present invention provides a substituted benzoyl compound and its application in agriculture; specifically, the present invention provides a compound represented by formula (I) and a preparation method thereof; compositions and preparations containing these compounds and their use as Use of herbicides; wherein Q is oxocyclohexenyl or substituted pyrazolyl; R 1 , R 2 , R 3 , R 4 and R 5 are each independently hydrogen, halogen, cyano, hydroxyl and the like.
Figure DDA0002355877150000011

Description

取代的苯甲酰类化合物及其在农业中的应用Substituted benzoyl compounds and their applications in agriculture

技术领域technical field

本发明提供一种新的取代的苯甲酰类化合物及其制备方法;含有这些化合物的组合物及其在农业中的应用。The present invention provides a new substituted benzoyl compound and its preparation method; a composition containing these compounds and its application in agriculture.

背景技术Background technique

取代的苯甲酰类化合物是一类具有优良生物活性的化合物,其除草活性报道在例如CN 107674025、CN 108264484和EP 137963中描述。然而,在下文中详细描述的本发明化合物没有在这些文献中描述过。Substituted benzoyl compounds are a class of compounds with excellent biological activity, the herbicidal activities of which are reported in eg CN 107674025, CN 108264484 and EP 137963. However, the compounds of the present invention described in detail hereinafter are not described in these documents.

从以上引用的文献中所知的活性成分在使用中具有的不利之处在于,例如(a)对杂草植物没有或者仅具有不足够的除草作用、(b)待防治的杂草植物谱过窄或者(c)在有用植物作物中的选择性过低。The active ingredients known from the documents cited above have disadvantages in use in that, for example, (a) there is no or only insufficient herbicidal action on weed plants, (b) the weed plants to be controlled are overused narrow or (c) too low selectivity in crops of useful plants.

因此,需要提供可有利地用作除草剂或植物生长调节剂的化学活性成分。Therefore, there is a need to provide chemically active ingredients that can be advantageously used as herbicides or plant growth regulators.

发明内容SUMMARY OF THE INVENTION

本发明提供一种新的取代的苯甲酰类化合物,具有优良的除草作用以及在农作物与杂草之间的优良选择性。The present invention provides a novel substituted benzoyl compound with excellent herbicidal action and excellent selectivity between crops and weeds.

一方面,本发明提供式(I)所示的化合物或式(I)所示化合物的立体异构体、互变异构体、氮氧化物及盐:In one aspect, the present invention provides compounds represented by formula (I) or stereoisomers, tautomers, nitrogen oxides and salts of compounds represented by formula (I):

Figure BDA0002355877140000011
Figure BDA0002355877140000011

其中:in:

R1、R2、R3、R4和R5各自独立地为氢、卤素、氰基、羟基、硝基、氨基、羧基、烷基、烯基、炔基、卤代烷基、卤代烯基、卤代炔基、烷氧基、卤代烷氧基、烷硫基、烷氨基、环烷基、杂环基、芳基、杂芳基、环烷基烷基、杂环基烷基、芳基烷基、杂芳基烷基、环烷基氧基、杂环基氧基、芳氧基或杂芳氧基;R 1 , R 2 , R 3 , R 4 and R 5 are each independently hydrogen, halogen, cyano, hydroxy, nitro, amino, carboxyl, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl , haloalkynyl, alkoxy, haloalkoxy, alkylthio, alkylamino, cycloalkyl, heterocyclyl, aryl, heteroaryl, cycloalkylalkyl, heterocyclylalkyl, aryl alkyl, heteroarylalkyl, cycloalkyloxy, heterocyclyloxy, aryloxy or heteroaryloxy;

Q为以下子结构式:Q is the following substructure formula:

Figure BDA0002355877140000012
Figure BDA0002355877140000012

其中Ra和Rb各自独立地为氢、烷基或环烷基;wherein R a and R b are each independently hydrogen, alkyl or cycloalkyl;

R1、R2、R3、R4、R5、Rb和Ra各自独立任选地被1、2、3、4、5或6个选自Rc的取代基所取代;R 1 , R 2 , R 3 , R 4 , R 5 , R b and Ra are each independently optionally substituted with 1, 2, 3, 4, 5 or 6 substituents selected from R c ;

各Rc独立地为氟、氯、溴、碘、氨基、硝基、氰基、羟基、羧基、C1-8烷基、卤代C1-8烷基、C2-8烯基、卤代C2-8烯基、C2-8炔基、卤代C2-8炔基、C1-8烷氧基、卤代C1-8烷氧基、C1-8烷氨基、C1-8烷硫基、卤代C1-8烷氨基、卤代C1-8烷硫基、C6-10芳基、C6-10芳氧基、C1-9杂芳基或C1-9杂芳氧基。Each R c is independently fluoro, chloro, bromo, iodo, amino, nitro, cyano, hydroxy, carboxyl, C 1-8 alkyl, haloC 1-8 alkyl, C 2-8 alkenyl, halo Substituted C 2-8 alkenyl, C 2-8 alkynyl, halogenated C 2-8 alkynyl, C 1-8 alkoxy, halogenated C 1-8 alkoxy, C 1-8 alkylamino, C 1-8 alkylthio, halogenated C 1-8 alkylamino, halogenated C 1-8 alkylthio, C 6-10 aryl, C 6-10 aryloxy, C 1-9 heteroaryl or C 1-9 Heteroaryloxy.

其中一些实施方案中,R1、R2、R3、R4和R5各自独立地为氢、卤素、氰基、羟基、硝基、氨基、羧基、C1-8烷基、C2-8烯基、C2-8炔基、卤代C1-8烷基、卤代C2-8烯基、卤代C2-8炔基、C1-8烷氧基、卤代C1-8烷氧基、C1-8烷硫基、C1-8烷氨基、C3-10环烷基、C2-12杂环基、C6-14芳基、C1-9杂芳基、C3-10环烷基C1-8烷基、C2-12杂环基C1-8烷基、C6-14芳基C1-8烷基、C1-9杂芳基C1-8烷基、C3-10环烷基氧基、C2-12杂环基氧基、C6-14芳氧基或C1-9杂芳氧基;In some of these embodiments, R 1 , R 2 , R 3 , R 4 and R 5 are each independently hydrogen, halogen, cyano, hydroxyl, nitro, amino, carboxyl, C 1-8 alkyl, C 2- 8 alkenyl, C 2-8 alkynyl, halo C 1-8 alkyl, halo C 2-8 alkenyl, halo C 2-8 alkynyl, C 1-8 alkoxy, halo C 1 -8 alkoxy, C 1-8 alkylthio, C 1-8 alkylamino, C 3-10 cycloalkyl, C 2-12 heterocyclyl, C 6-14 aryl, C 1-9 heteroaryl base, C 3-10 cycloalkyl C 1-8 alkyl, C 2-12 heterocyclyl C 1-8 alkyl, C 6-14 aryl C 1-8 alkyl, C 1-9 heteroaryl C 1-8 alkyl, C 3-10 cycloalkyloxy, C 2-12 heterocyclyloxy, C 6-14 aryloxy or C 1-9 heteroaryloxy;

R1、R2、R3、R4和R5各自独立任选地被1、2、3、4、5或6个选自Rc的取代基所取代;R 1 , R 2 , R 3 , R 4 and R 5 are each independently optionally substituted with 1, 2, 3, 4, 5 or 6 substituents selected from R c ;

各Rc独立地为氟、氯、溴、碘、氨基、硝基、氰基、羟基、羧基、C1-6烷基、卤代C1-6烷基、C2-6烯基、卤代C2-6烯基、C2-6炔基、卤代C2-6炔基、C1-6烷氧基、卤代C1-6烷氧基、C1-6烷氨基、C1-6烷硫基、卤代C1-6烷氨基、卤代C1-6烷硫基、C6-10芳基、C6-10芳氧基、C1-6杂芳基或C1-6杂芳氧基。Each R c is independently fluorine, chlorine, bromine, iodine, amino, nitro, cyano, hydroxy, carboxyl, C 1-6 alkyl, haloC 1-6 alkyl, C 2-6 alkenyl, halo Substituted C 2-6 alkenyl, C 2-6 alkynyl, halogenated C 2-6 alkynyl, C 1-6 alkoxy, halogenated C 1-6 alkoxy, C 1-6 alkylamino, C 1-6 alkylthio, halogenated C 1-6 alkylamino, halogenated C 1-6 alkylthio, C 6-10 aryl, C 6-10 aryloxy, C 1-6 heteroaryl or C 1-6 Heteroaryloxy.

另外一些实施方案中,R1、R2、R3、R4和R5各自独立地为氢、卤素、氰基、羟基、硝基、氨基、羧基、C1-6烷基、C2-6烯基、C2-6炔基、卤代C1-6烷基、卤代C2-6烯基、卤代C2-6炔基、C1-6烷氧基、卤代C1-6烷氧基、C1-6烷硫基、C1-6烷氨基、C3-8环烷基、C2-8杂环基、C6-10芳基、C1-6杂芳基、C3-8环烷基C1-6烷基、C2-8杂环基C1-6烷基、C6-10芳基C1-6烷基、C1-6杂芳基C1-6烷基、C3-8环烷基氧基、C2-8杂环基氧基、C6-10芳氧基或C1-6杂芳氧基;In other embodiments, R 1 , R 2 , R 3 , R 4 , and R 5 are each independently hydrogen, halogen, cyano, hydroxy, nitro, amino, carboxyl, C 1-6 alkyl, C 2- 6 alkenyl, C 2-6 alkynyl, halo C 1-6 alkyl, halo C 2-6 alkenyl, halo C 2-6 alkynyl, C 1-6 alkoxy, halo C 1 -6 alkoxy, C 1-6 alkylthio, C 1-6 alkylamino, C 3-8 cycloalkyl, C 2-8 heterocyclyl, C 6-10 aryl, C 1-6 heteroaryl base, C 3-8 cycloalkyl C 1-6 alkyl, C 2-8 heterocyclyl C 1-6 alkyl, C 6-10 aryl C 1-6 alkyl, C 1-6 heteroaryl C 1-6 alkyl, C 3-8 cycloalkyloxy, C 2-8 heterocyclyloxy, C 6-10 aryloxy or C 1-6 heteroaryloxy;

R1、R2、R3、R4和R5各自独立任选地被1、2、3、4、5或6个选自Rc的取代基所取代;R 1 , R 2 , R 3 , R 4 and R 5 are each independently optionally substituted with 1, 2, 3, 4, 5 or 6 substituents selected from R c ;

各Rc独立地为氟、氯、溴、碘、氨基、硝基、氰基、羟基、羧基、C1-4烷基、卤代C1-4烷基、C2-4烯基、卤代C2-4烯基、C2-4炔基、卤代C2-4炔基、C1-4烷氧基、卤代C1-4烷氧基、C1-4烷氨基、C1-4烷硫基、卤代C1-4烷氨基、卤代C1-4烷硫基、C6-10芳基、C6-10芳氧基、C1-6杂芳基或C1-6杂芳氧基。Each R c is independently fluorine, chlorine, bromine, iodine, amino, nitro, cyano, hydroxy, carboxyl, C 1-4 alkyl, haloC 1-4 alkyl, C 2-4 alkenyl, halo Substituted C 2-4 alkenyl, C 2-4 alkynyl, halogenated C 2-4 alkynyl, C 1-4 alkoxy, halogenated C 1-4 alkoxy, C 1-4 alkylamino, C 1-4 alkylthio, halogenated C 1-4 alkylamino, halogenated C 1-4 alkylthio, C 6-10 aryl, C 6-10 aryloxy, C 1-6 heteroaryl or C 1-6 Heteroaryloxy.

另外一些实施方案中,R1、R2、R3、R4和R5各自独立地为氢、卤素、氰基、羟基、硝基、氨基、羧基、C1-4烷基、C2-4烯基、C2-4炔基、卤代C1-4烷基、卤代C2-4烯基、卤代C2-4炔基、C1-4烷氧基、卤代C1-4烷氧基、C1-4烷硫基、C1-4烷氨基、C3-6环烷基、C2-6杂环基、C6-10芳基、C1-5杂芳基、C3-6环烷基C1-3烷基、C2-6杂环基C1-3烷基、C6-10芳基C1-3烷基、C1-5杂芳基C1-3烷基、C3-6环烷基氧基、C2-6杂环基氧基、C6-10芳氧基或C1-5杂芳氧基;In other embodiments, R 1 , R 2 , R 3 , R 4 , and R 5 are each independently hydrogen, halogen, cyano, hydroxyl, nitro, amino, carboxyl, C 1-4 alkyl, C 2- 4 alkenyl, C 2-4 alkynyl, halo C 1-4 alkyl, halo C 2-4 alkenyl, halo C 2-4 alkynyl, C 1-4 alkoxy, halo C 1 -4 alkoxy, C 1-4 alkylthio, C 1-4 alkylamino, C 3-6 cycloalkyl, C 2-6 heterocyclyl, C 6-10 aryl, C 1-5 heteroaryl base, C 3-6 cycloalkyl C 1-3 alkyl, C 2-6 heterocyclyl C 1-3 alkyl, C 6-10 aryl C 1-3 alkyl, C 1-5 heteroaryl C 1-3 alkyl, C 3-6 cycloalkyloxy, C 2-6 heterocyclyloxy, C 6-10 aryloxy or C 1-5 heteroaryloxy;

R1、R2、R3、R4和R5各自独立任选地被1、2、3、4、5或6个选自Rc的取代基所取代;R 1 , R 2 , R 3 , R 4 and R 5 are each independently optionally substituted with 1, 2, 3, 4, 5 or 6 substituents selected from R c ;

各Rc独立地为氟、氯、溴、碘、氨基、硝基、氰基、羟基、羧基、甲基、乙基、正丙基、异丙基、二氟甲基、三氟甲基、甲氧基或三氟甲氧基。Each R is independently fluorine, chlorine, bromine, iodine, amino, nitro, cyano, hydroxy, carboxyl, methyl, ethyl, n-propyl, isopropyl, difluoromethyl, trifluoromethyl, Methoxy or trifluoromethoxy.

其中一些实施方案中,Ra和Rb各自独立地为氢、C1-6烷基或C3-8环烷基。In some of these embodiments, R a and R b are each independently hydrogen, C 1-6 alkyl, or C 3-8 cycloalkyl.

另外一些实施方案中,Ra和Rb各自独立地为氢、C1-4烷基或C3-6环烷基。In other embodiments, R a and R b are each independently hydrogen, C 1-4 alkyl, or C 3-6 cycloalkyl.

其中一些实施方案中,本发明提供一种化合物,其为如式(Ia)所示的化合物或式(Ia)所示化合物的立体异构体、互变异构体、氮氧化物或盐:In some of these embodiments, the present invention provides a compound that is a compound of formula (Ia) or a stereoisomer, tautomer, nitrogen oxide or salt of a compound of formula (Ia):

Figure BDA0002355877140000021
Figure BDA0002355877140000021

其中Q、R1、R2、R3、R4和R5具有如本发明所述的含义。wherein Q, R 1 , R 2 , R 3 , R 4 and R 5 have the meanings as described in the present invention.

其中一些实施方案中,本发明提供一种化合物,其为如式(Ib)所示的化合物或式(Ib)所示化合物的立体异构体、互变异构体、氮氧化物或盐:In some of these embodiments, the present invention provides a compound that is a compound of formula (Ib) or a stereoisomer, tautomer, nitrogen oxide or salt of a compound of formula (Ib):

Figure BDA0002355877140000031
Figure BDA0002355877140000031

其中Q、R1、R2、R3、R4和R5具有如本发明所述的含义。wherein Q, R 1 , R 2 , R 3 , R 4 and R 5 have the meanings as described in the present invention.

其中一些实施方案中,本发明提供一种化合物,其为如式(Ic)所示的化合物或式(Ic)所示化合物的立体异构体、互变异构体、氮氧化物或盐:In some of these embodiments, the present invention provides a compound that is a compound of formula (Ic) or a stereoisomer, tautomer, nitrogen oxide or salt of a compound of formula (Ic):

Figure BDA0002355877140000032
Figure BDA0002355877140000032

其中Q、R1、R2、R3、R4和R5具有如本发明所述的含义。wherein Q, R 1 , R 2 , R 3 , R 4 and R 5 have the meanings as described in the present invention.

另外一些实施方案中,Q为以下子结构式:In other embodiments, Q is the following substructural formula:

Figure BDA0002355877140000033
Figure BDA0002355877140000033

其中Ra和Rb各自独立地为氢、甲基、乙基或环丙基;wherein R a and R b are each independently hydrogen, methyl, ethyl or cyclopropyl;

R1、R2、R3、R4和R5各自独立地为氢、卤素、氰基、羟基、硝基、氨基、羧基、甲基、乙基、正丙基、异丙基、二氟甲基、三氟甲基、甲氧基、乙氧基、二氟甲氧基或三氟甲氧基。R 1 , R 2 , R 3 , R 4 and R 5 are each independently hydrogen, halogen, cyano, hydroxyl, nitro, amino, carboxyl, methyl, ethyl, n-propyl, isopropyl, difluoro Methyl, trifluoromethyl, methoxy, ethoxy, difluoromethoxy or trifluoromethoxy.

另一方面,本发明提供一种组合物,包含本发明所述的化合物,进一步任选地包含至少一种附加组分。In another aspect, the present invention provides a composition comprising a compound described herein, further optionally comprising at least one additional component.

另一方面,本发明提供包含本发明所述化合物的组合物在农业中的应用。In another aspect, the present invention provides the use in agriculture of a composition comprising the compound of the present invention.

进一步地,本发明提供包含本发明所述化合物的组合物在植物病害防治中的应用。Further, the present invention provides the application of the composition comprising the compound of the present invention in the control of plant diseases.

其中一些实施方案中,本发明提供包含本发明所述化合物的组合物用于防治不想要的植物的用途。In some of these embodiments, the present invention provides the use of a composition comprising a compound of the present invention for controlling unwanted plants.

另一方面,本发明提供防治不想要的植物的方法,其特征在于将有效量的本发明所述化合物施用于植物、植物种子、其中或其上生长植物的土壤,或栽培区域。In another aspect, the present invention provides a method of controlling unwanted plants, characterized in that an effective amount of the compound of the present invention is applied to plants, plant seeds, soil in which or on which plants grow, or cultivated areas.

式(I)、式(Ia)、式(Ib)或式(Ic)所示的化合物可能以不同的立体异构体或光学异构体或互变异构形式存在。本发明包含所有此类异构体和互变异构体及其各种比例的混合物,以及同位素形式例如含重氢的化合物。Compounds of formula (I), formula (Ia), formula (Ib) or formula (Ic) may exist in different stereoisomeric or optical isomers or tautomeric forms. The present invention includes all such isomers and tautomers and mixtures thereof in various ratios, as well as isotopic forms such as deuterium containing compounds.

同位素富集的化合物具有本发明给出的通式描绘的结构,除了一个或多个原子被具有所选择原子量或质量数的原子替换。可引入本发明化合物中的示例性同位素包括氢、碳、氮、氧、磷、硫、氟和氯的同位素,如2H,3H,11C,13C,14C,15N,17O,18O,18F,31P,32P,35S,36Cl和125I。Isotopically enriched compounds have the structures depicted by the general formulae given herein, except that one or more atoms are replaced by atoms having a selected atomic weight or mass number. Exemplary isotopes that can be incorporated into the compounds of the present invention include isotopes of hydrogen , carbon, nitrogen, oxygen, phosphorus, sulfur, fluorine, and chlorine, such as 2H, 3H , 11C , 13C , 14C , 15N , 17O , 18 O, 18 F, 31 P, 32 P, 35 S, 36 Cl and 125 I.

本发明公开化合物的任何不对称原子(例如,碳等)都可以以外消旋或对映体富集的形式存在,例如(R)-、(S)-或(R,S)-构型形式存在。Any asymmetric atom (eg, carbon, etc.) of the compounds disclosed herein may exist in racemic or enantiomerically enriched forms, such as (R)-, (S)- or (R,S)-configurations exist.

前面所述内容只概述了本发明的某些方面,但并不限于这些方面及其他方面的内容将在下面作更加具体完整的描述。The foregoing merely outlines certain aspects of the present invention, but is not limited to these and other aspects, which will be described in greater detail below.

本发明的详细说明Detailed Description of the Invention

定义和一般术语Definitions and General Terms

现在详细描述本发明的某些实施方案,其实例由随附的结构式和化学式说明。本发明意图涵盖所有的替代、修改和等同技术方案,它们均包括在如权利要求定义的本发明范围内。本领域技术人员应认识到,许多与本发明所述类似或等同的方法和材料能够用于实践本发明。本发明绝不限于本发明所述的方法和材料。在所结合的文献、专利和类似材料的一篇或多篇与本申请不同或相矛盾的情况下(包括但不限于所定义的术语、术语应用、所描述的技术,等等),以本申请为准。Certain embodiments of the invention will now be described in detail, examples of which are illustrated by the accompanying structural and chemical formulae. The present invention is intended to cover all alternatives, modifications and equivalents, which are included within the scope of the present invention as defined by the claims. One skilled in the art will recognize that many methods and materials similar or equivalent to those described herein could be used in the practice of the present invention. The present invention is in no way limited to the methods and materials described herein. In the event that one or more of the incorporated literature, patents, and similar materials differs from or contradicts this application (including, but not limited to, terms defined, uses of terms, techniques described, etc.), this Application shall prevail.

应进一步认识到,本发明的某些特征,为清楚可见,在多个独立的实施方案中进行了描述,但也可以在单个实施例中以组合形式提供。反之,本发明的各种特征,为简洁起见,在单个实施方案中进行了描述,但也可以单独或以任意适合的子组合提供。It should further be appreciated that certain features of the invention, which are, for clarity, described in the context of multiple separate embodiments, can also be provided in combination in a single embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, can also be provided separately or in any suitable subcombination.

除非另外说明,本发明所使用的所有科技术语具有与本发明所属领域技术人员的通常理解相同的含义。本发明涉及的所有专利和公开出版物通过引用方式整体并入本发明。Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. All patents and publications referred to herein are incorporated by reference in their entirety.

除非另外说明,应当应用本发明所使用的下列定义。出于本发明的目的,化学元素与元素周期表CAS版,和《化学和物理手册》,第75版,1994一致。此外,有机化学一般原理可参考"Organic Chemistry",Thomas Sorrell,University Science Books,Sausalito:1999,和"March's Advanced Organic Chemistry"by Michael B.Smith and JerryMarch,John Wiley&Sons,New York:2007中的描述,其全部内容通过引用并入本发明。Unless otherwise stated, the following definitions used herein shall apply. For the purposes of the present invention, chemical elements are in accordance with the Periodic Table of the Elements, CAS Edition, and Handbook of Chemistry and Physics, 75th Edition, 1994. In addition, general principles of organic chemistry may be referred to as described in "Organic Chemistry", Thomas Sorrell, University Science Books, Sausalito: 1999, and "March's Advanced Organic Chemistry" by Michael B. Smith and Jerry March, John Wiley & Sons, New York: 2007, Its entire contents are incorporated herein by reference.

除非另有说明或者上下文中有明显的冲突,本文所使用的冠词“一”、“一个(种)”和“所述”旨在包括“至少一个”或“一个或多个”。因此,本文所使用的这些冠词是指一个或多于一个(即至少一个)宾语的冠词。例如,“一组分”指一个或多个组分,即可能有多于一个的组分被考虑在所述实施方案的实施方式中采用或使用。As used herein, the articles "a", "an" and "the" are intended to include "at least one" or "one or more" unless stated otherwise or otherwise clearly contradicted by context. Thus, as used herein, these articles refer to one or more than one (ie, at least one) object of the article. For example, "a component" refers to one or more components, ie, there may be more than one component contemplated for use or use in the implementation of the described embodiments.

术语“包含”为开放式表达,即包括本发明所指明的内容,但并不排除其他方面的内容。The term "comprising" is an open-ended expression, that is, it includes the contents specified in the present invention, but does not exclude other aspects.

“立体异构体”是指具有相同化学构造,但原子或基团在空间上排列方式不同的化合物。立体异构体包括对映异构体、非对映异构体、构象异构体(旋转异构体)、几何异构体(顺/反)异构体、阻转异构体,等等。"Stereoisomers" refer to compounds that have the same chemical structure, but differ in the arrangement of atoms or groups in space. Stereoisomers include enantiomers, diastereomers, conformational isomers (rotamers), geometric isomers (cis/trans), atropisomers, etc. .

“对映异构体”是指一个化合物的两个不能重叠但互成镜像关系的异构体。"Enantiomer" refers to two nonsuperimposable, but mirror-image isomers of a compound.

“非对映异构体”是指有两个或多个手性中性并且其分子不互为镜像的立体异构体。非对映异构体具有不同的物理性质,如熔点、沸点、光谱性质和反应性。非对映异构体混合物可通过高分辨分析操作如电泳和色谱,例如HPLC来分离。"Diastereomer" refers to a stereoisomer that has two or more chiral neutralities and whose molecules are not mirror images of each other. Diastereomers have different physical properties such as melting point, boiling point, spectral properties and reactivity. Diastereomeric mixtures can be separated by high resolution analytical procedures such as electrophoresis and chromatography, eg HPLC.

本发明所使用的立体化学定义和规则一般遵循S.P.Parker,Ed.,McGraw-HillDictionary of Chemical Terms(1984)McGraw-Hill Book Company,New York;andEliel,E.and Wilen,S.,“Stereochemistry of Organic Compounds”,John Wiley&Sons,Inc.,New York,1994中所描述的立体化学定义和规则。Stereochemical definitions and rules used in the present invention generally follow S.P. Parker, Ed., McGraw-Hill Dictionary of Chemical Terms (1984) McGraw-Hill Book Company, New York; and Eliel, E. and Wilen, S., "Stereochemistry of Organic Compounds", definitions and rules for stereochemistry as described in John Wiley & Sons, Inc., New York, 1994.

许多有机化合物以光学活性形式存在,即它们具有使平面偏振光的平面发生旋转的能力。在描述光学活性化合物时,使用前缀D和L或R和S来表示分子关于其一个或多个手性中心的绝对构型。前缀d和l或(+)和(-)是用于指定化合物所致平面偏振光旋转的符号,其中(-)或l表示化合物是左旋的。前缀为(+)或d的化合物是右旋的。一种具体的立体异构体是对映异构体,这种异构体的混合物称作对映异构体混合物。对映异构体的50:50混合物称为外消旋混合物或外消旋体,当在化学反应或过程中没有立体选择性或立体特异性时,可出现这种情况。Many organic compounds exist in optically active forms, that is, they have the ability to rotate the plane of plane-polarized light. In describing optically active compounds, the prefixes D and L or R and S are used to denote the absolute configuration of the molecule about one or more of its chiral centers. The prefixes d and 1 or (+) and (-) are symbols used to designate the rotation of plane polarized light by the compound, where (-) or 1 indicates that the compound is levorotatory. Compounds prefixed with (+) or d are dextrorotatory. A specific stereoisomer is an enantiomer, and a mixture of such isomers is called an enantiomeric mixture. A 50:50 mixture of enantiomers is called a racemic mixture or racemate, which can occur when there is no stereoselectivity or stereospecificity in a chemical reaction or process.

术语“互变异构体”或“互变异构形式”是指具有不同能量的可通过低能垒(lowenergy barrier)互相转化的结构异构体。若互变异构是可能的(如在溶液中),则可以达到互变异构体的化学平衡。例如,质子互变异构体(protontautomer)(也称为质子转移互变异构体(prototropic tautomer))包括通过质子迁移来进行的互相转化,如酮-烯醇异构化和亚胺-烯胺异构化。价键互变异构体(valence tautomer)包括通过一些成键电子的重组来进行的互相转化。酮-烯醇互变异构的具体实例是戊烷-2,4-二酮、己烷-1,3-二酮和4-羟基戊-3-烯-2-酮互变异构体的互变。互变异构的另一个实例是酚-酮互变异构。酚-酮互变异构的一个具体实例是吡啶-4-醇和吡啶-4(1H)-酮互变异构体的互变。除非另外指出,本发明化合物的所有互变异构体形式都在本发明的范围之内。The term "tautomer" or "tautomeric form" refers to structural isomers of different energies that are interconvertible through a low energy barrier. A chemical equilibrium of tautomers can be achieved if tautomerism is possible (eg, in solution). For example, protontautomers (also known as prototropic tautomers) include interconversions by migration of protons, such as keto-enol isomerization and imine-ene Amine isomerization. Valence tautomers include interconversions by recombination of some of the bonding electrons. Specific examples of keto-enol tautomers are pentane-2,4-dione, hexane-1,3-dione and 4-hydroxypent-3-en-2-one tautomers Mutual transformation. Another example of tautomerism is phenol-ketone tautomerism. A specific example of phenol-ketone tautomerism is the interconversion of pyridin-4-ol and pyridin-4(lH)-one tautomers. Unless otherwise indicated, all tautomeric forms of the compounds of the present invention are within the scope of the present invention.

本发明中,取决于外在条件(诸如溶剂、pH等),存在酮-烯醇的互变:In the present invention, depending on external conditions (such as solvent, pH, etc.), there is a keto-enol interconversion:

Figure BDA0002355877140000051
Figure BDA0002355877140000051

像本发明所描述的,本发明的化合物可以任选地被一个或多个取代基所取代,如上面的通式化合物,或者像实施例里面特殊的例子,子类,和本发明所包含的一类化合物。应了解“任选取代的”这个术语与“取代或非取代的”这个术语可以交换使用。一般而言,术语“取代的”表示所给结构中的一个或多个氢原子被具体取代基所取代。除非其他方面表明,一个任选的取代基团可以在基团各个可取代的位置进行取代。当所给出的结构式中不只一个位置能被选自具体基团的一个或多个取代基所取代,那么取代基可以相同或不同地在各个位置取代。其中所述的取代基可以是,但并不限于,氘,氟,氯,溴,碘,氰基,羟基,硝基,氨基,羧基,烷基,烷氧基,烷氧基烷基,烷氧基烷氧基,烷氧基烷氨基,芳氧基,杂芳基氧基,杂环基氧基,芳基烷氧基,杂芳基烷氧基,杂环基烷氧基,环烷基烷氧基,烷氨基,烷氨基烷基,烷氨基烷氨基,环烷基氨基,环烷基烷氨基,烷硫基,卤代烷基,卤代烷氧基,羟基取代的烷基,羟基取代的烷氨基,氰基取代的烷基,氰基取代的烷氧基,氰基取代的烷氨基,氨基取代的烷基,烷基酰基,杂烷基,环烷基,环烯基,环烷基烷基,杂环基,杂环基烷基,杂环基酰基,芳基,芳基烷基,芳氨基,杂芳基,杂芳基烷基,杂芳基氨基,酰胺基,磺酰基,氨基磺酰基等等。As described herein, the compounds of the present invention may be optionally substituted with one or more substituents, such as the compounds of the general formula above, or as in the Examples, subclasses, and subclasses encompassed by the present invention. a class of compounds. It is to be understood that the term "optionally substituted" is used interchangeably with the term "substituted or unsubstituted". In general, the term "substituted" means that one or more hydrogen atoms in a given structure have been replaced with a specified substituent. Unless otherwise indicated, an optional substituent group may be substituted at each substitutable position of the group. When more than one position in a given formula can be substituted with one or more substituents selected from a particular group, the substituents can be substituted identically or differently at each position. The substituents mentioned therein can be, but are not limited to, deuterium, fluorine, chlorine, bromine, iodine, cyano, hydroxyl, nitro, amino, carboxyl, alkyl, alkoxy, alkoxyalkyl, alkane Oxyalkoxy, alkoxyalkylamino, aryloxy, heteroaryloxy, heterocyclyloxy, arylalkoxy, heteroarylalkoxy, heterocyclylalkoxy, cycloalkane Alkoxy, alkylamino, alkylaminoalkyl, alkylaminoalkylamino, cycloalkylamino, cycloalkylalkylamino, alkylthio, haloalkyl, haloalkoxy, hydroxy-substituted alkyl, hydroxy-substituted alkane Amino, cyano-substituted alkyl, cyano-substituted alkoxy, cyano-substituted alkylamino, amino-substituted alkyl, alkylacyl, heteroalkyl, cycloalkyl, cycloalkenyl, cycloalkylalkane radical, heterocyclyl, heterocyclylalkyl, heterocyclylacyl, aryl, arylalkyl, arylamino, heteroaryl, heteroarylalkyl, heteroarylamino, amido, sulfonyl, amino Sulfonyl, etc.

另外,需要说明的是,除非以其他方式明确指出,在本发明中所采用的描述方式“各…独立地为”与“…各自独立地为”和“…独立地为”可以互换,均应做广义理解,其既可以是指在不同基团中,相同符号之间所表达的具体选项之间互相不影响,也可以表示在相同的基团中,相同符号之间所表达的具体选项之间互相不影响。In addition, it should be noted that, unless clearly stated otherwise, the description modes "each independently" and "...independently" and "...independently" used in the present invention can be interchanged, and both are interchangeable. It should be understood in a broad sense. It can either mean that in different groups, the specific options expressed between the same symbols do not affect each other, or it can mean that in the same group, the specific options expressed between the same symbols do not affect each other.

在本说明书的各部分,本发明公开化合物的取代基按照基团种类或范围公开。特别指出,本发明包括这些基团种类和范围的各个成员的每一个独立的次级组合。例如,术语“C1-C6烷基”或“C1-6烷基”特别指独立公开的甲基、乙基、C3烷基、C4烷基、C5烷基和C6烷基。In various parts of this specification, the substituents of the compounds disclosed in the present invention are disclosed in terms of group type or scope. Specifically, the present invention includes each and every independent subcombination of each member of these group species and ranges. For example, the term " C1 - C6 alkyl" or " C1-6 alkyl" specifically refers to the independently disclosed methyl, ethyl, C3 alkyl, C4 alkyl, C5 alkyl and C6 alkanes base.

本发明使用的术语“烷基”或“烷基基团”,表示含有1至20个碳原子,饱和的直链或支链一价烃基基团;其中所述烷基基团任选地被一个或多个本发明描述的取代基所取代。除非另外详细说明,烷基基团含有1-20个碳原子。在一实施方案中,烷基基团含有1-12个碳原子;在一实施方案中,烷基基团含有1-10个碳原子;在一实施方案中,烷基基团含有1-8个碳原子;在另一实施方案中,烷基基团含有1-6个碳原子;在又一实施方案中,烷基基团含有1-4个碳原子;还在一实施方案中,烷基基团含有1-3个碳原子。As used herein, the term "alkyl" or "alkyl group" refers to a saturated straight or branched chain monovalent hydrocarbon group containing 1 to 20 carbon atoms; wherein the alkyl group is optionally substituted with one or more of the substituents described herein. Unless otherwise specified, alkyl groups contain 1-20 carbon atoms. In one embodiment, the alkyl group contains 1-12 carbon atoms; in one embodiment, the alkyl group contains 1-10 carbon atoms; in one embodiment, the alkyl group contains 1-8 carbon atoms; in another embodiment, the alkyl group contains 1-6 carbon atoms; in yet another embodiment, the alkyl group contains 1-4 carbon atoms; in yet another embodiment, the alkane group Radical groups contain 1-3 carbon atoms.

烷基基团的实例包含,但并不限于,甲基(Me、-CH3),乙基(Et、-CH2CH3),正丙基(n-Pr、-CH2CH2CH3),异丙基(i-Pr、-CH(CH3)2),正丁基(n-Bu、-CH2CH2CH2CH3),异丁基(i-Bu、-CH2CH(CH3)2),仲丁基(s-Bu、-CH(CH3)CH2CH3),叔丁基(t-Bu、-C(CH3)3),正戊基(-CH2CH2CH2CH2CH3),2-戊基(-CH(CH3)CH2CH2CH3),3-戊基(-CH(CH2CH3)2),2-甲基-2-丁基(-C(CH3)2CH2CH3),3-甲基-2-丁基(-CH(CH3)CH(CH3)2),3-甲基-1-丁基(-CH2CH2CH(CH3)2),2-甲基-1-丁基(-CH2CH(CH3)CH2CH3),正己基(-CH2CH2CH2CH2CH2CH3),2-己基(-CH(CH3)CH2CH2CH2CH3),3-己基(-CH(CH2CH3)(CH2CH2CH3)),2-甲基-2-戊基(-C(CH3)2CH2CH2CH3),3-甲基-2-戊基(-CH(CH3)CH(CH3)CH2CH3),4-甲基-2-戊基(-CH(CH3)CH2CH(CH3)2),3-甲基-3-戊基(-C(CH3)(CH2CH3)2),2-甲基-3-戊基(-CH(CH2CH3)CH(CH3)2),2,3-二甲基-2-丁基(-C(CH3)2CH(CH3)2),3,3-二甲基-2-丁基(-CH(CH3)C(CH3)3),正庚基,正辛基,等等。Examples of alkyl groups include, but are not limited to, methyl (Me, -CH3 ), ethyl (Et, -CH2CH3), n - propyl (n - Pr, -CH2CH2CH3 ) ), isopropyl (i-Pr, -CH(CH 3 ) 2 ), n-butyl (n-Bu, -CH 2 CH 2 CH 2 CH 3 ), isobutyl (i-Bu, -CH 2 CH ) (CH 3 ) 2 ), sec-butyl (s-Bu, -CH(CH 3 )CH 2 CH 3 ), tert-butyl (t-Bu, -C(CH 3 ) 3 ), n-pentyl (-CH 2CH2CH2CH2CH3), 2 -pentyl (-CH( CH3 ) CH2CH2CH3 ) , 3 - pentyl (-CH( CH2CH3 ) 2 ) , 2 -methyl -2-butyl(-C(CH3)2CH2CH3), 3 -methyl- 2-butyl(-CH(CH3)CH(CH3)2 ) , 3 - methyl -1- Butyl ( -CH2CH2CH ( CH3 ) 2 ), 2 -methyl- 1 -butyl (-CH2CH( CH3 ) CH2CH3 ) , n - hexyl ( -CH2CH2CH2 CH2CH2CH3 ), 2 -hexyl (-CH( CH3 ) CH2CH2CH2CH3 ) , 3 - hexyl (-CH( CH2CH3 ) ( CH2CH2CH3 ) ) , 2-methyl-2-pentyl(-C( CH3 )2CH2CH2CH3), 3 -methyl- 2 -pentyl(-CH( CH3 ) CH ( CH3 ) CH2CH3 ), 4-methyl-2-pentyl (-CH(CH 3 )CH 2 CH(CH 3 ) 2 ), 3-methyl-3-pentyl (-C(CH 3 )(CH 2 CH 3 ) 2 ), 2-methyl-3-pentyl (-CH(CH 2 CH 3 )CH(CH 3 ) 2 ), 2,3-dimethyl-2-butyl (-C(CH 3 ) 2 CH (CH 3 ) 2 ), 3,3-dimethyl-2-butyl (-CH(CH 3 )C(CH 3 ) 3 ), n-heptyl, n-octyl, and the like.

术语“烯基”表示含有2-12个碳原子的直链或支链一价烃基,其中至少有一个不饱和位点,即有一个碳-碳sp2双键,其中,所述烯基基团可以任选地被一个或多个本发明所描述的取代基所取代,其包括“cis”和“tans”的定位,或者“E”和“Z”的定位。在一实施方案中,烯基基团包含2-10个碳原子;在一实施方案中,烯基基团包含2-8个碳原子;在另一实施方案中,烯基基团包含2-6个碳原子;在又一实施方案中,烯基基团包含2-4个碳原子。烯基基团的实例包括,但并不限于,乙烯基(-CH=CH2),烯丙基(-CH2CH=CH2),丙烯基(CH3-CH=CH-),-CH2CH2CH=CH2、-CH2CH=CHCH3、-CH2CH2CH2CH=CH2、-CH2CH2CH=CHCH3、-CH2CH2CH2CH=CHCH3等等。The term "alkenyl" refers to a linear or branched monovalent hydrocarbon group containing 2 to 12 carbon atoms, wherein there is at least one site of unsaturation, i.e., a carbon-carbon sp 2 double bond, wherein the alkenyl group A group can be optionally substituted with one or more substituents described herein, including the "cis" and "tans" positions, or the "E" and "Z" positions. In one embodiment, an alkenyl group contains 2-10 carbon atoms; in one embodiment, an alkenyl group contains 2-8 carbon atoms; in another embodiment, an alkenyl group contains 2- 6 carbon atoms; in yet another embodiment, the alkenyl group contains 2-4 carbon atoms. Examples of alkenyl groups include, but are not limited to, vinyl (-CH= CH2 ), allyl (-CH2CH= CH2 ), propenyl ( CH3 - CH=CH-), -CH 2 CH 2 CH = CH 2 , -CH 2 CH = CHCH 3 , -CH 2 CH 2 CH 2 CH = CH 2 , -CH 2 CH 2 CH = CHCH 3 , -CH 2 CH 2 CH 2 CH = CHCH 3 , etc. Wait.

术语“炔基”表示含有2-12个碳原子的直链或支链一价烃基,其中至少有一个碳-碳sp三键,其中,所述炔基基团可以任选地被一个或多个本发明所描述的取代基所取代。在一实施方案中,炔基基团包含2-10个碳原子;在一实施方案中,炔基基团包含2-8个碳原子;在另一实施方案中,炔基基团包含2-6个碳原子;在又一实施方案中,炔基基团包含2-4个碳原子。炔基基团的实例包括,但并不限于,-C≡CH、-C≡CCH3、-CH2-C≡CH、-CH2-C≡CCH3、-CH2CH2-C≡CH、-CH2-C≡CCH2CH3、-CH2CH2-C≡C-CH2CH3等等。The term "alkynyl" refers to a straight or branched chain monovalent hydrocarbon group containing 2 to 12 carbon atoms, wherein there is at least one carbon-carbon sp triple bond, wherein the alkynyl group may be optionally combined with one or more substituted with one of the substituents described in the present invention. In one embodiment, the alkynyl group contains 2-10 carbon atoms; in one embodiment, the alkynyl group contains 2-8 carbon atoms; in another embodiment, the alkynyl group contains 2- 6 carbon atoms; in yet another embodiment, the alkynyl group contains 2-4 carbon atoms. Examples of alkynyl groups include, but are not limited to, -C≡CH, -C≡CCH3 , -CH2 -C≡CH, -CH2 - C≡CCH3 , -CH2CH2 - C≡CH , -CH 2 -C≡CCH 2 CH 3 , -CH 2 CH 2 -C≡C-CH 2 CH 3 and so on.

术语“烷氧基”表示烷基基团通过氧原子与分子其余部分相连,其中烷基基团具有如本发明所述的含义。除非另外详细说明,所述烷氧基基团含有1-12个碳原子。在一实施方案中,烷氧基基团含有1-10个碳原子;在一实施方案中,烷氧基基团含有1-8个碳原子;在一实施方案中,烷氧基基团含有1-6个碳原子;在另一实施方案中,烷氧基基团含有1-4个碳原子;在又一实施方案中,烷氧基基团含有1-3个碳原子。所述烷氧基基团可以任选地被一个或多个本发明描述的取代基所取代。The term "alkoxy" means that an alkyl group is attached to the remainder of the molecule through an oxygen atom, wherein the alkyl group has the meaning as described herein. Unless otherwise specified, the alkoxy groups contain 1-12 carbon atoms. In one embodiment, the alkoxy group contains 1-10 carbon atoms; in one embodiment, the alkoxy group contains 1-8 carbon atoms; in one embodiment, the alkoxy group contains 1-6 carbon atoms; in another embodiment, the alkoxy group contains 1-4 carbon atoms; in yet another embodiment, the alkoxy group contains 1-3 carbon atoms. The alkoxy groups may be optionally substituted with one or more substituents described herein.

烷氧基基团的实例包括,但并不限于,甲氧基(MeO、-OCH3),乙氧基(EtO、-OCH2CH3),1-丙氧基(n-PrO、n-丙氧基、-OCH2CH2CH3),2-丙氧基(i-PrO、i-丙氧基、-OCH(CH3)2),1-丁氧基(n-BuO、n-丁氧基、-OCH2CH2CH2CH3),2-甲基-l-丙氧基(i-BuO、i-丁氧基、-OCH2CH(CH3)2),2-丁氧基(s-BuO、s-丁氧基、-OCH(CH3)CH2CH3),2-甲基-2-丙氧基(t-BuO、t-丁氧基、-OC(CH3)3),1-戊氧基(n-戊氧基、-OCH2CH2CH2CH2CH3),2-戊氧基(-OCH(CH3)CH2CH2CH3),3-戊氧基(-OCH(CH2CH3)2),2-甲基-2-丁氧基(-OC(CH3)2CH2CH3),3-甲基-2-丁氧基(-OCH(CH3)CH(CH3)2),3-甲基-l-丁氧基(-OCH2CH2CH(CH3)2),2-甲基-l-丁氧基(-OCH2CH(CH3)CH2CH3),等等。Examples of alkoxy groups include, but are not limited to, methoxy (MeO, -OCH 3 ), ethoxy (EtO, -OCH 2 CH 3 ), 1-propoxy (n-PrO, n- Propoxy, -OCH 2 CH 2 CH 3 ), 2-propoxy (i-PrO, i-propoxy, -OCH(CH 3 ) 2 ), 1-butoxy (n-BuO, n- Butoxy, -OCH 2 CH 2 CH 2 CH 3 ), 2-methyl-l-propoxy (i-BuO, i-butoxy, -OCH 2 CH(CH 3 ) 2 ), 2-butanyl Oxy (s-BuO, s-butoxy, -OCH(CH 3 )CH 2 CH 3 ), 2-methyl-2-propoxy (t-BuO, t-butoxy, -OC(CH 3 ) 3 ), 1 -pentyloxy (n - pentyloxy, -OCH2CH2CH2CH2CH3), 2 - pentyloxy (-OCH ( CH3 ) CH2CH2CH3 ) , 3-pentyloxy (-OCH(CH 2 CH 3 ) 2 ), 2-methyl-2-butoxy (-OC(CH 3 ) 2 CH 2 CH 3 ), 3-methyl-2-butoxy group (-OCH(CH 3 )CH(CH 3 ) 2 ), 3-methyl-1-butoxy (-OCH 2 CH 2 CH(CH 3 ) 2 ), 2-methyl-1-butoxy (-OCH 2 CH(CH 3 )CH 2 CH 3 ), etc.

术语“烷基氨基”或“烷氨基”包括“N-烷基氨基”和“N,N-二烷基氨基”,其中氨基基团分别独立地被一个或两个烷基基团所取代。其中一些实施例是,烷基氨基是一个或两个C1-6烷基连接到氮原子上的较低级的烷基氨基基团。另外一些实施例是,烷基氨基是C1-3的较低级的烷基氨基基团。合适的烷基氨基基团可以是单烷基氨基或二烷基氨基,这样的实例包括,但并不限于,N-甲氨基,N-乙氨基,N,N-二甲氨基,N,N-二乙氨基等等。The term "alkylamino" or "alkylamino" includes "N-alkylamino" and "N,N-dialkylamino" wherein the amino group is independently substituted with one or two alkyl groups, respectively. In some embodiments, alkylamino is a lower alkylamino group with one or two C1-6 alkyl groups attached to a nitrogen atom. In other embodiments, the alkylamino group is a C1-3 lower alkylamino group. Suitable alkylamino groups may be monoalkylamino or dialkylamino, examples of which include, but are not limited to, N-methylamino, N-ethylamino, N,N-dimethylamino, N,N -Diethylamino, etc.

术语“烷硫基”指直链或支链的烷基连接到二价的硫原子上,其中烷基基团具有如本发明所述的含义。烷硫基基团的实例包括,但并不限于,-SCH3、-SCH2CH3、-SCH2CH2CH3等等。The term "alkylthio" refers to a straight or branched chain alkyl group attached to a divalent sulfur atom, wherein the alkyl group has the meaning as described herein. Examples of alkylthio groups include, but are not limited to, -SCH3 , -SCH2CH3 , -SCH2CH2CH3 , and the like.

术语“卤素”是指氟(F)、氯(Cl)、溴(Br)或碘(I)。The term "halogen" refers to fluorine (F), chlorine (Cl), bromine (Br) or iodine (I).

术语“卤代烷基”表示烷基基团被一个或多个卤素原子所取代。卤代烷基的实例包括,但并不限于,-CH2F,-CHF2,-CH2Cl,-CH2Br,-CF3,-CH2CF3,-CH2CH2F,-CH2CH2Cl,-CH2CH2Br,-CH2CHF2,-CH2CH2CF3,-CH2CH2CH2F,-CH2CH2CH2Cl,-CH2CH2CH2Br,-CHFCH2CH3,-CHClCH2CH3,等等。The term "haloalkyl" means an alkyl group substituted with one or more halogen atoms. Examples of haloalkyl groups include, but are not limited to, -CH2F , -CHF2 , -CH2Cl , -CH2Br , -CF3 , -CH2CF3 , -CH2CH2F , -CH2 CH2Cl , -CH2CH2Br , -CH2CHF2 , -CH2CH2CF3 , -CH2CH2CH2F , -CH2CH2CH2Cl , -CH2CH2CH2 _ _ _ _ Br , -CHFCH2CH3 , -CHClCH2CH3 , etc.

术语“卤代烷氧基”表示烷氧基基团被一个或多个卤素原子所取代。卤代烷氧基的实例包括,但并不限于,-OCH2F,-OCHF2,-OCH2Cl,-OCH2Br,-OCF3,-OCH2CF3,-OCH2CH2F,-OCH2CH2Cl,-OCH2CH2Br,-OCH2CHF2,-OCH2CH2CF3,-OCH2CH2CH2F,-OCH2CH2CH2Cl,-OCH2CH2CH2Br,-OCHFCH2CH3,-OCHClCH2CH3,等等。The term "haloalkoxy" refers to an alkoxy group substituted with one or more halogen atoms. Examples of haloalkoxy groups include, but are not limited to, -OCH2F , -OCHF2 , -OCH2Cl , -OCH2Br , -OCF3 , -OCH2CF3 , -OCH2CH2F , -OCH 2CH2Cl , -OCH2CH2Br , -OCH2CHF2 , -OCH2CH2CF3 , -OCH2CH2CH2F , -OCH2CH2CH2Cl , -OCH2CH2CH _ _ _ _ 2Br , -OCHFCH2CH3 , -OCHClCH2CH3 , etc.

术语“卤代烷氨基”表示烷氨基基团被一个或多个卤素原子所取代。The term "haloalkylamino" refers to an alkylamino group substituted with one or more halogen atoms.

术语“卤代烷硫基”表示烷硫基基团被一个或多个卤素原子所取代。The term "haloalkylthio" means an alkylthio group substituted with one or more halogen atoms.

术语“卤代烯基”表示烯基基团被一个或多个卤素原子所取代。The term "haloalkenyl" means an alkenyl group substituted with one or more halogen atoms.

术语“卤代炔基”表示炔基基团被一个或多个卤素原子所取代。The term "haloalkynyl" means an alkynyl group substituted with one or more halogen atoms.

术语“环烷基”表示含有3-12个碳原子的,单价或多价的饱和单环、双环或三环体系。在一实施方案中,环烷基包含3-12个碳原子;在一实施方案中,环烷基包含3-10个碳原子;在另一实施方案中,环烷基包含3-8个碳原子;在又一实施方案中,环烷基包含3-6个碳原子。所述环烷基基团任选地被一个或多个本发明所描述的取代基所取代。这样的实例包括,但并不限于,环丙基,环丁基,环戊基,环己基,环庚基,环辛基,环壬基,环癸基,环十一烷基,环十二烷基,金刚烷基,等等。The term "cycloalkyl" denotes a monovalent or polyvalent saturated monocyclic, bicyclic or tricyclic ring system containing 3 to 12 carbon atoms. In one embodiment, the cycloalkyl group contains 3-12 carbon atoms; in one embodiment, the cycloalkyl group contains 3-10 carbon atoms; in another embodiment, the cycloalkyl group contains 3-8 carbon atoms atom; in yet another embodiment, the cycloalkyl group contains 3-6 carbon atoms. The cycloalkyl group is optionally substituted with one or more substituents described herein. Such examples include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, cyclodecyl, cycloundecyl, cyclododecyl Alkyl, adamantyl, etc.

术语“环烷基烷基”表示烷基基团被环烷基基团取代,其中烷基基团和环烷基基团具有如本发明所述的含义。The term "cycloalkylalkyl" means that an alkyl group is substituted with a cycloalkyl group, wherein the alkyl group and the cycloalkyl group have the meanings as described herein.

术语“环烷基氧基”表示环烷基,如本发明所定义的,连接到氧原子上,并且由氧原子与分子其余部分相连,其中环烷基基团具有如本发明所述的含义。The term "cycloalkyloxy" refers to a cycloalkyl group, as defined herein, attached to an oxygen atom and by the oxygen atom to the rest of the molecule, wherein the cycloalkyl group has the meaning as defined herein .

在本发明中所使用的术语“不饱和的”表示基团中含有一个或多个不饱和度。The term "unsaturated" as used herein means that the group contains one or more degrees of unsaturation.

术语“杂原子”是指O、S、N、P和Si,包括N、S和P任何氧化态的形式;伯、仲、叔胺和季铵盐的形式;或者杂环中氮原子上的氢被取代的形式,例如,N(像3,4-二氢-2H-吡咯基中的N),NH(像吡咯烷基中的NH)或NR(像N-取代的吡咯烷基中的NR)。The term "heteroatom" refers to O, S, N, P, and Si, including N, S, and P in any oxidation state; in the form of primary, secondary, tertiary amines, and quaternary ammonium salts; or on a nitrogen atom in a heterocyclic ring. Hydrogen substituted form, for example, N (like N in 3,4-dihydro-2H-pyrrolidinyl), NH (like NH in pyrrolidinyl) or NR (like in N-substituted pyrrolidinyl) NR).

术语“杂环基”和“杂环”在此处可交换使用,都是指包含3-15个环原子的饱和或部分不饱和的单环、双环或三环,其中单环、双环或三环中不包含芳香环,且至少一个环原子选自氮、硫和氧原子。除非另外说明,杂环基可以是碳基或氮基,且-CH2-基团可以任选地被-C(=O)-替代。环的硫原子可以任选地被氧化成S-氧化物。环的氮原子可以任选地被氧化成N-氧化合物。杂环基的实例包括,但不限于,环氧乙烷基,氮杂环丁基,氧杂环丁基,硫杂环丁基,吡咯烷基(如2-吡咯烷基),2-吡咯啉基,3-吡咯啉基,吡唑烷基,咪唑啉基,咪唑烷基,四氢呋喃基,二氢呋喃基,四氢噻吩基,二氢噻吩基,1,3-二氧环戊基,二硫环戊基,四氢吡喃基,二氢吡喃基,2H-吡喃基,4H-吡喃基,四氢噻喃基,哌啶基(2-哌啶基,3-哌啶基,4-哌啶基),吗啉基,硫代吗啉基,(1-氧代)-硫代吗啉基,(1,1-二氧代)-硫代吗啉基,哌嗪基,二噁烷基,二噻烷基,噻噁烷基,高哌嗪基,高哌啶基,氧杂环庚烷基,硫杂环庚烷基,2-氧杂-5-氮杂双环[2.2.1]庚-5-基,四氢吡啶基。杂环基中-CH2-基团被-C(=O)-取代的实例包括,但不限于,2-氧代吡咯烷基,氧代-1,3-噻唑烷基,2-哌啶酮基,3,5-二氧代哌啶基。杂环基中硫原子被氧化的实例包括,但不限于,环丁砜基,1,1-二氧代硫代吗啉基。所述杂环基基团任选地被一个或多个本发明所描述的取代基所取代。The terms "heterocyclyl" and "heterocycle" are used interchangeably herein, and both refer to a saturated or partially unsaturated monocyclic, bicyclic or tricyclic ring containing 3 to 15 ring atoms, wherein a monocyclic, bicyclic or tricyclic ring The ring contains no aromatic rings and at least one ring atom is selected from nitrogen, sulfur and oxygen atoms. Unless otherwise specified, heterocyclyl can be carbon or nitrogen, and -CH2- groups can be optionally replaced by -C(=O)-. Ring sulfur atoms can optionally be oxidized to S-oxides. The nitrogen atoms of the rings can be optionally oxidized to N-oxygen compounds. Examples of heterocyclyl groups include, but are not limited to, oxiranyl, azetidinyl, oxetanyl, thietanyl, pyrrolidinyl (eg 2-pyrrolidinyl), 2-pyrrole Linyl, 3-pyrrolinyl, pyrazolidinyl, imidazolinyl, imidazolidinyl, tetrahydrofuranyl, dihydrofuranyl, tetrahydrothienyl, dihydrothienyl, 1,3-dioxocyclopentyl, Dithiocyclopentyl, tetrahydropyranyl, dihydropyranyl, 2H-pyranyl, 4H-pyranyl, tetrahydrothiopyranyl, piperidinyl (2-piperidinyl, 3-piperidine base, 4-piperidinyl), morpholinyl, thiomorpholinyl, (1-oxo)-thiomorpholinyl, (1,1-dioxo)-thiomorpholinyl, piperazine base, dioxanyl, dithianyl, thioxanyl, homopiperazinyl, homopiperidinyl, oxepanyl, thiepanyl, 2-oxa-5-aza Bicyclo[2.2.1]hept-5-yl, tetrahydropyridyl. Examples of heterocyclyl groups where the -CH2- group is substituted with -C(=O)- include, but are not limited to, 2-oxopyrrolidinyl, oxo-1,3-thiazolidinyl, 2-piperidine Keto, 3,5-dioxopiperidinyl. Examples of oxidized sulfur atoms in a heterocyclyl group include, but are not limited to, sulfolanyl, 1,1-dioxothiomorpholinyl. The heterocyclyl group is optionally substituted with one or more substituents described herein.

术语“杂环基烷基”是指杂环基取代的烷基;其中杂环基和烷基基团具有如本发明所述的含义。The term "heterocyclylalkyl" refers to a heterocyclyl-substituted alkyl group; wherein the heterocyclyl and alkyl groups have the meanings as described herein.

术语“杂环基氧基”包括任选取代的杂环基,如本发明所定义的,连接到氧原子上,并且由氧原子与分子其余部分相连,其中杂环基基团具有如本发明所述的含义。The term "heterocyclyloxy" includes an optionally substituted heterocyclyl group, as defined herein, attached to an oxygen atom and connected to the remainder of the molecule by the oxygen atom, wherein the heterocyclyl group has as defined herein said meaning.

术语“芳基”表示含有6-14个环原子,或6-12个环原子,或6-10个环原子的单环、双环和三环的碳环体系,其中,至少一个环体系是芳香族的,其中每一个环体系包含3-7个原子组成的环,且有一个或多个附着点与分子的其余部分相连。术语“芳基”可以和术语“芳香环”交换使用。芳基基团的实例可以包括苯基,茚基,萘基和蒽基。所述芳基基团任选地被一个或多个本发明所描述的取代基所取代。The term "aryl" refers to monocyclic, bicyclic and tricyclic carbocyclic ring systems containing 6-14 ring atoms, or 6-12 ring atoms, or 6-10 ring atoms, wherein at least one ring system is aromatic A family of rings in which each ring system contains a ring of 3-7 atoms with one or more points of attachment to the rest of the molecule. The term "aryl" is used interchangeably with the term "aromatic ring". Examples of aryl groups may include phenyl, indenyl, naphthyl, and anthracenyl. The aryl group is optionally substituted with one or more substituents described herein.

术语“芳基烷基”或“芳烷基”表示烷基被一个或多个芳基基团所取代,其中烷基和芳基基团具有如本发明所述的含义。The term "arylalkyl" or "aralkyl" means that an alkyl group is substituted with one or more aryl groups, wherein the alkyl and aryl groups have the meanings as described herein.

术语“芳氧基”或“芳基氧基”包括任选取代的芳基,如本发明所定义的,连接到氧原子上,并且由氧原子与分子其余部分相连,其中芳基基团具有如本发明所述的含义。The term "aryloxy" or "aryloxy" includes an optionally substituted aryl group, as defined herein, attached to an oxygen atom and through the oxygen atom to the remainder of the molecule, wherein the aryl group has meaning as described in the present invention.

术语“杂芳基”表示含有5-12个环原子,或5-10个环原子,或5-6个环原子的单环、双环和三环体系,其中至少一个环体系是芳香族的,且至少一个环体系包含一个或多个杂原子,其中每一个环体系包含5-7个原子组成的环,且有一个或多个附着点与分子其余部分相连。术语“杂芳基”可以与术语“杂芳环”或“杂芳族化合物”交换使用。所述杂芳基基团任选地被一个或多个本发明所描述的取代基所取代。The term "heteroaryl" refers to monocyclic, bicyclic and tricyclic ring systems containing 5-12 ring atoms, or 5-10 ring atoms, or 5-6 ring atoms, wherein at least one ring system is aromatic, And at least one ring system contains one or more heteroatoms, wherein each ring system contains a ring of 5-7 atoms and has one or more points of attachment to the rest of the molecule. The term "heteroaryl" may be used interchangeably with the terms "heteroaromatic ring" or "heteroaromatic". The heteroaryl group is optionally substituted with one or more substituents described herein.

在一实施方案中,5-10个原子组成的杂芳基包含1,2,3或4个独立选自O,S和N的杂原子。In one embodiment, a heteroaryl group of 5-10 atoms contains 1, 2, 3 or 4 heteroatoms independently selected from O, S and N.

在另一实施方案中,杂芳基的环原子包含1-9个碳原子和1-4个选自N、O或S的杂原子;在另一实施方案中,杂芳基的环原子包含1-5个碳原子和1-4个选自N、O或S的杂原子。In another embodiment, the ring atoms of the heteroaryl group contain 1-9 carbon atoms and 1-4 heteroatoms selected from N, O, or S; in another embodiment, the ring atoms of the heteroaryl group contain 1-5 carbon atoms and 1-4 heteroatoms selected from N, O or S.

在又一实施方案中,杂芳基表示含1-4个N杂原子的5元或6元杂芳基;在又一实施方案中,杂芳基表示含1-3个选自N、O或S的杂原子的5元杂芳基;在又一实施方案中,杂芳基表示含1-3个选自N或O的杂原子的5元杂芳基;在又一实施方案中,杂芳基表示含1-3个选自N或S的杂原子的5元杂芳基。In yet another embodiment, heteroaryl represents a 5- or 6-membered heteroaryl group containing 1-4 N heteroatoms; in yet another embodiment, heteroaryl represents a group containing 1-3 N, O or a 5-membered heteroaryl of a heteroatom of S; in yet another embodiment, heteroaryl represents a 5-membered heteroaryl containing 1-3 heteroatoms selected from N or O; in yet another embodiment, Heteroaryl means a 5-membered heteroaryl group containing 1-3 heteroatoms selected from N or S.

杂芳基基团的实例包括,但并不限于,2-呋喃基,3-呋喃基,N-咪唑基,2-咪唑基,4-咪唑基,5-咪唑基,3-异噁唑基,4-异噁唑基,5-异噁唑基,2-噁唑基,4-噁唑基,5-噁唑基,N-吡咯基,2-吡咯基,3-吡咯基,2-吡啶基,3-吡啶基,4-吡啶基,2-嘧啶基,4-嘧啶基,5-嘧啶基,哒嗪基(如3-哒嗪基),2-噻唑基,4-噻唑基,5-噻唑基,四唑基(如5-四唑基),三唑基(如2-三唑基和5-三唑基),2-噻吩基,3-噻吩基,吡唑基,异噻唑基,1,2,3-噁二唑基,1,2,5-噁二唑基,1,2,4-噁二唑基,1,2,3-三唑基,1,2,3-硫代二唑基,1,3,4-硫代二唑基,1,2,5-硫代二唑基,吡嗪基,1,3,5-三嗪基,嘧啶酮基,吡啶酮基;也包括以下的双环,但绝不限于这些双环:苯并咪唑基,苯并呋喃基,苯并四氢呋喃基,苯并噻吩基,吲哚基(如2-吲哚基),等等。Examples of heteroaryl groups include, but are not limited to, 2-furyl, 3-furyl, N-imidazolyl, 2-imidazolyl, 4-imidazolyl, 5-imidazolyl, 3-isoxazolyl , 4-isoxazolyl, 5-isoxazolyl, 2-oxazolyl, 4-oxazolyl, 5-oxazolyl, N-pyrrolyl, 2-pyrrolyl, 3-pyrrolyl, 2- Pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl, pyridazinyl (such as 3-pyridazinyl), 2-thiazolyl, 4-thiazolyl, 5-thiazolyl, tetrazolyl (such as 5-tetrazolyl), triazolyl (such as 2-triazolyl and 5-triazolyl), 2-thienyl, 3-thienyl, pyrazolyl, iso Thiazolyl, 1,2,3-oxadiazolyl, 1,2,5-oxadiazolyl, 1,2,4-oxadiazolyl, 1,2,3-triazolyl, 1,2, 3-thioadiazolyl, 1,3,4-thiodiazolyl, 1,2,5-thiodiazolyl, pyrazinyl, 1,3,5-triazinyl, pyrimidinone, Pyridonyl; also including, but in no way limited to, the following bicyclic rings: benzimidazolyl, benzofuranyl, benzotetrahydrofuranyl, benzothienyl, indolyl (eg 2-indolyl), etc. Wait.

术语“杂芳基烷基”表示烷基基团被一个或多个杂芳基基团所取代,其中烷基基团和杂芳基基团具有如本发明所述的含义。The term "heteroarylalkyl" means that an alkyl group is substituted with one or more heteroaryl groups, wherein the alkyl group and the heteroaryl group have the meanings as described herein.

术语“杂芳基氧基”或“杂芳氧基”包括任选取代的杂芳基,如本发明所定义的,连接到氧原子上,并且由氧原子与分子其余部分相连,其中杂芳基基团具有如本发明所述的含义。The term "heteroaryloxy" or "heteroaryloxy" includes an optionally substituted heteroaryl group, as defined herein, attached to an oxygen atom and through the oxygen atom to the remainder of the molecule, wherein heteroaryl The radical group has the meaning as described in the present invention.

当本发明的化合物包含一个酸部分时,本发明所述化合物的盐,包括衍生自碱金属或碱土金属的那些以及衍生自氨和胺的那些。优选的阳离子包括钠、钾、镁以及具有化学式N+(R19R20R21R22)的铵阳离子,其中R19、R20、R21和R22独立地选自氢、C1-C6烷基和C1-C6羟基烷基。具有式(I)、式(Ia)、式(Ib)或式(Ic)所示的化合物的盐可以通过用金属氢氧化物(例如氢氧化钠)或胺(例如氨、三甲胺、二乙醇胺、2-甲硫基丙胺、双烯丙基胺、2-丁氧基乙胺、吗啉、环十二胺或苄胺)对具有式(I)、式(Ia)、式(Ib)或式(Ic)所示的化合物进行处理来制备。When the compounds of the present invention contain an acid moiety, salts of the compounds of the present invention include those derived from alkali or alkaline earth metals and those derived from ammonia and amines. Preferred cations include sodium, potassium, magnesium, and ammonium cations of formula N + (R 19 R 20 R 21 R 22 ), wherein R 19 , R 20 , R 21 and R 22 are independently selected from hydrogen, C 1 -C 6 alkyl and C 1 -C 6 hydroxyalkyl. Salts of compounds of formula (I), formula (Ia), formula (Ib) or formula (Ic) can be prepared by using metal hydroxides (eg sodium hydroxide) or amines (eg ammonia, trimethylamine, diethanolamine) , 2-methylthiopropylamine, bisallylamine, 2-butoxyethylamine, morpholine, cyclododecylamine or benzylamine) for formula (I), formula (Ia), formula (Ib) or The compound represented by formula (Ic) is processed to prepare.

当本发明的化合物包含一个碱部分时,可接受的盐可以由有机酸和无机酸形成,例如乙酸、丙酸、乳酸、柠檬酸、酒石酸、琥珀酸、富马酸、马来酸、丙二酸、扁桃酸、苹果酸、邻苯二甲酸、盐酸、氢溴酸、磷酸、硝酸、硫酸、甲磺酸、萘磺酸、苯磺酸、甲苯磺酸、樟脑磺酸以及类似地已知可接受的酸。When the compounds of the present invention contain a base moiety, acceptable salts can be formed with organic and inorganic acids, such as acetic, propionic, lactic, citric, tartaric, succinic, fumaric, maleic, malonic acid, mandelic acid, malic acid, phthalic acid, hydrochloric acid, hydrobromic acid, phosphoric acid, nitric acid, sulfuric acid, methanesulfonic acid, naphthalenesulfonic acid, benzenesulfonic acid, toluenesulfonic acid, camphorsulfonic acid and similarly known Accepted acid.

本发明化合物的详细描述DETAILED DESCRIPTION OF THE COMPOUNDS OF THE INVENTION

本发明的目的在于提供一种新型取代的苯甲酰类化合物、含有该化合物的除草剂组合物和制剂及其应用。The purpose of the present invention is to provide a novel substituted benzoyl compound, herbicidal compositions and formulations containing the compound, and applications thereof.

一方面,本发明提供一种化合物,其为如式(I)所示的化合物或式(I)所示化合物的立体异构体、互变异构体、氮氧化物及盐:In one aspect, the present invention provides a compound, which is a compound represented by formula (I) or a stereoisomer, tautomer, nitrogen oxide and salt of the compound represented by formula (I):

Figure BDA0002355877140000091
Figure BDA0002355877140000091

其中:in:

R1、R2、R3、R4和R5各自独立地为氢、卤素、氰基、羟基、硝基、氨基、羧基、烷基、烯基、炔基、卤代烷基、卤代烯基、卤代炔基、烷氧基、卤代烷氧基、烷硫基、烷氨基、环烷基、杂环基、芳基、杂芳基、环烷基烷基、杂环基烷基、芳基烷基、杂芳基烷基、环烷基氧基、杂环基氧基、芳氧基或杂芳氧基;R 1 , R 2 , R 3 , R 4 and R 5 are each independently hydrogen, halogen, cyano, hydroxy, nitro, amino, carboxyl, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl , haloalkynyl, alkoxy, haloalkoxy, alkylthio, alkylamino, cycloalkyl, heterocyclyl, aryl, heteroaryl, cycloalkylalkyl, heterocyclylalkyl, aryl alkyl, heteroarylalkyl, cycloalkyloxy, heterocyclyloxy, aryloxy or heteroaryloxy;

Q为以下子结构式:Q is the following substructure formula:

Figure BDA0002355877140000092
Figure BDA0002355877140000092

其中Ra和Rb各自独立地为氢、烷基或环烷基;wherein R a and R b are each independently hydrogen, alkyl or cycloalkyl;

R1、R2、R3、R4、R5、Rb和Ra各自独立任选地被1、2、3、4、5或6个选自Rc的取代基所取代;R 1 , R 2 , R 3 , R 4 , R 5 , R b and Ra are each independently optionally substituted with 1, 2, 3, 4, 5 or 6 substituents selected from R c ;

各Rc独立地为氟、氯、溴、碘、氨基、硝基、氰基、羟基、羧基、C1-8烷基、卤代C1-8烷基、C2-8烯基、卤代C2-8烯基、C2-8炔基、卤代C2-8炔基、C1-8烷氧基、卤代C1-8烷氧基、C1-8烷氨基、C1-8烷硫基、卤代C1-8烷氨基、卤代C1-8烷硫基、C6-10芳基、C6-10芳氧基、C1-9杂芳基或C1-9杂芳氧基。Each R c is independently fluoro, chloro, bromo, iodo, amino, nitro, cyano, hydroxy, carboxyl, C 1-8 alkyl, haloC 1-8 alkyl, C 2-8 alkenyl, halo Substituted C 2-8 alkenyl, C 2-8 alkynyl, halogenated C 2-8 alkynyl, C 1-8 alkoxy, halogenated C 1-8 alkoxy, C 1-8 alkylamino, C 1-8 alkylthio, halogenated C 1-8 alkylamino, halogenated C 1-8 alkylthio, C 6-10 aryl, C 6-10 aryloxy, C 1-9 heteroaryl or C 1-9 Heteroaryloxy.

其中一些实施方案中,R1、R2、R3、R4和R5各自独立地为氢、卤素、氰基、羟基、硝基、氨基、羧基、C1-8烷基、C2-8烯基、C2-8炔基、卤代C1-8烷基、卤代C2-8烯基、卤代C2-8炔基、C1-8烷氧基、卤代C1-8烷氧基、C1-8烷硫基、C1-8烷氨基、C3-10环烷基、C2-12杂环基、C6-14芳基、C1-9杂芳基、C3-10环烷基C1-8烷基、C2-12杂环基C1-8烷基、C6-14芳基C1-8烷基、C1-9杂芳基C1-8烷基、C3-10环烷基氧基、C2-12杂环基氧基、C6-14芳氧基或C1-9杂芳氧基;In some of these embodiments, R 1 , R 2 , R 3 , R 4 and R 5 are each independently hydrogen, halogen, cyano, hydroxyl, nitro, amino, carboxyl, C 1-8 alkyl, C 2- 8 alkenyl, C 2-8 alkynyl, halo C 1-8 alkyl, halo C 2-8 alkenyl, halo C 2-8 alkynyl, C 1-8 alkoxy, halo C 1 -8 alkoxy, C 1-8 alkylthio, C 1-8 alkylamino, C 3-10 cycloalkyl, C 2-12 heterocyclyl, C 6-14 aryl, C 1-9 heteroaryl base, C 3-10 cycloalkyl C 1-8 alkyl, C 2-12 heterocyclyl C 1-8 alkyl, C 6-14 aryl C 1-8 alkyl, C 1-9 heteroaryl C 1-8 alkyl, C 3-10 cycloalkyloxy, C 2-12 heterocyclyloxy, C 6-14 aryloxy or C 1-9 heteroaryloxy;

R1、R2、R3、R4和R5各自独立任选地被1、2、3、4、5或6个选自Rc的取代基所取代;R 1 , R 2 , R 3 , R 4 and R 5 are each independently optionally substituted with 1, 2, 3, 4, 5 or 6 substituents selected from R c ;

其中各Rc具有本发明所述的含义。wherein each R c has the meaning described in the present invention.

另外一些实施方案中,R1、R2、R3、R4和R5各自独立地为氢、卤素、氰基、羟基、硝基、氨基、羧基、C1-6烷基、C2-6烯基、C2-6炔基、卤代C1-6烷基、卤代C2-6烯基、卤代C2-6炔基、C1-6烷氧基、卤代C1-6烷氧基、C1-6烷硫基、C1-6烷氨基、C3-8环烷基、C2-8杂环基、C6-10芳基、C1-6杂芳基、C3-8环烷基C1-6烷基、C2-8杂环基C1-6烷基、C6-10芳基C1-6烷基、C1-6杂芳基C1-6烷基、C3-8环烷基氧基、C2-8杂环基氧基、C6-10芳氧基或C1-6杂芳氧基;In other embodiments, R 1 , R 2 , R 3 , R 4 , and R 5 are each independently hydrogen, halogen, cyano, hydroxy, nitro, amino, carboxyl, C 1-6 alkyl, C 2- 6 alkenyl, C 2-6 alkynyl, halo C 1-6 alkyl, halo C 2-6 alkenyl, halo C 2-6 alkynyl, C 1-6 alkoxy, halo C 1 -6 alkoxy, C 1-6 alkylthio, C 1-6 alkylamino, C 3-8 cycloalkyl, C 2-8 heterocyclyl, C 6-10 aryl, C 1-6 heteroaryl base, C 3-8 cycloalkyl C 1-6 alkyl, C 2-8 heterocyclyl C 1-6 alkyl, C 6-10 aryl C 1-6 alkyl, C 1-6 heteroaryl C 1-6 alkyl, C 3-8 cycloalkyloxy, C 2-8 heterocyclyloxy, C 6-10 aryloxy or C 1-6 heteroaryloxy;

R1、R2、R3、R4和R5各自独立任选地被1、2、3、4、5或6个选自Rc的取代基所取代;R 1 , R 2 , R 3 , R 4 and R 5 are each independently optionally substituted with 1, 2, 3, 4, 5 or 6 substituents selected from R c ;

其中各Rc具有本发明所述的含义。wherein each R c has the meaning described in the present invention.

另外一些实施方案中,R1、R2、R3、R4和R5各自独立地为氢、卤素、氰基、羟基、硝基、氨基、羧基、C1-4烷基、C2-4烯基、C2-4炔基、卤代C1-4烷基、卤代C2-4烯基、卤代C2-4炔基、C1-4烷氧基、卤代C1-4烷氧基、C1-4烷硫基、C1-4烷氨基、C3-6环烷基、C2-6杂环基、C6-10芳基、C1-5杂芳基、C3-6环烷基C1-3烷基、C2-6杂环基C1-3烷基、C6-10芳基C1-3烷基、C1-5杂芳基C1-3烷基、C3-6环烷基氧基、C2-6杂环基氧基、C6-10芳氧基或C1-5杂芳氧基;In other embodiments, R 1 , R 2 , R 3 , R 4 , and R 5 are each independently hydrogen, halogen, cyano, hydroxyl, nitro, amino, carboxyl, C 1-4 alkyl, C 2- 4 alkenyl, C 2-4 alkynyl, halo C 1-4 alkyl, halo C 2-4 alkenyl, halo C 2-4 alkynyl, C 1-4 alkoxy, halo C 1 -4 alkoxy, C 1-4 alkylthio, C 1-4 alkylamino, C 3-6 cycloalkyl, C 2-6 heterocyclyl, C 6-10 aryl, C 1-5 heteroaryl base, C 3-6 cycloalkyl C 1-3 alkyl, C 2-6 heterocyclyl C 1-3 alkyl, C 6-10 aryl C 1-3 alkyl, C 1-5 heteroaryl C 1-3 alkyl, C 3-6 cycloalkyloxy, C 2-6 heterocyclyloxy, C 6-10 aryloxy or C 1-5 heteroaryloxy;

R1、R2、R3、R4和R5各自独立任选地被1、2、3、4、5或6个选自Rc的取代基所取代;R 1 , R 2 , R 3 , R 4 and R 5 are each independently optionally substituted with 1, 2, 3, 4, 5 or 6 substituents selected from R c ;

其中各Rc具有本发明所述的含义。wherein each R c has the meaning described in the present invention.

另外一些实施方案中,R1、R2、R3、R4和R5各自独立地为氢、卤素、氰基、羟基、硝基、氨基、羧基、甲基、乙基、正丙基、异丙基、二氟甲基、三氟甲基、甲氧基、乙氧基、二氟甲氧基或三氟甲氧基。In other embodiments, R 1 , R 2 , R 3 , R 4 , and R 5 are each independently hydrogen, halogen, cyano, hydroxyl, nitro, amino, carboxyl, methyl, ethyl, n-propyl, isopropyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, difluoromethoxy or trifluoromethoxy.

其中一些实施方案中,各Rc独立地为氟、氯、溴、碘、氨基、硝基、氰基、羟基、羧基、C1-6烷基、卤代C1-6烷基、C2-6烯基、卤代C2-6烯基、C2-6炔基、卤代C2-6炔基、C1-6烷氧基、卤代C1-6烷氧基、C1-6烷氨基、C1-6烷硫基、卤代C1-6烷氨基、卤代C1-6烷硫基、C6-10芳基、C6-10芳氧基、C1-6杂芳基或C1-6杂芳氧基。In some of these embodiments, each R is independently fluoro, chloro, bromo, iodo, amino, nitro, cyano, hydroxy, carboxy, C 1-6 alkyl, haloC 1-6 alkyl, C 2 -6 alkenyl, haloC 2-6 alkenyl, C 2-6 alkynyl, halo C 2-6 alkynyl, C 1-6 alkoxy, halo C 1-6 alkoxy, C 1 -6 alkylamino, C 1-6 alkylthio, halogenated C 1-6 alkylamino, halogenated C 1-6 alkylthio, C 6-10 aryl, C 6-10 aryloxy, C 1- 6heteroaryl or C1-6heteroaryloxy .

另外一些实施方案中,各Rc独立地为氟、氯、溴、碘、氨基、硝基、氰基、羟基、羧基、C1-4烷基、卤代C1-4烷基、C2-4烯基、卤代C2-4烯基、C2-4炔基、卤代C2-4炔基、C1-4烷氧基、卤代C1-4烷氧基、C1-4烷氨基、C1-4烷硫基、卤代C1-4烷氨基、卤代C1-4烷硫基、C6-10芳基、C6-10芳氧基、C1-6杂芳基或C1-6杂芳氧基。In other embodiments, each Rc is independently fluoro, chloro, bromo, iodo, amino, nitro, cyano, hydroxy, carboxy, C1-4alkyl , haloC1-4alkyl , C2 -4 alkenyl, halogenated C 2-4 alkenyl, C 2-4 alkynyl, halogenated C 2-4 alkynyl, C 1-4 alkoxy, halogenated C 1-4 alkoxy, C 1 -4 alkylamino, C 1-4 alkylthio, halogenated C 1-4 alkylamino, halogenated C 1-4 alkylthio, C 6-10 aryl, C 6-10 aryloxy, C 1- 6heteroaryl or C1-6heteroaryloxy .

另外一些实施方案中,各Rc独立地为氟、氯、溴、碘、氨基、硝基、氰基、羟基、羧基、甲基、乙基、正丙基、异丙基、二氟甲基、三氟甲基、甲氧基或三氟甲氧基。In other embodiments, each R is independently fluoro , chloro, bromo, iodo, amino, nitro, cyano, hydroxy, carboxy, methyl, ethyl, n-propyl, isopropyl, difluoromethyl , trifluoromethyl, methoxy or trifluoromethoxy.

其中一些实施方案中,Ra和Rb各自独立地为氢、C1-8烷基或C3-12环烷基。In some of these embodiments, R a and R b are each independently hydrogen, C 1-8 alkyl, or C 3-12 cycloalkyl.

另外一些实施方案中,Ra和Rb各自独立地为氢、C1-6烷基或C3-8环烷基。In other embodiments, R a and R b are each independently hydrogen, C 1-6 alkyl, or C 3-8 cycloalkyl.

另外一些实施方案中,Ra和Rb各自独立地为氢、C1-4烷基或C3-6环烷基。In other embodiments, R a and R b are each independently hydrogen, C 1-4 alkyl, or C 3-6 cycloalkyl.

另外一些实施方案中,Ra和Rb各自独立地为氢、甲基、乙基或环丙基。In other embodiments, R a and R b are each independently hydrogen, methyl, ethyl, or cyclopropyl.

其中一些实施方案中,本发明提供一种化合物,其为如式(Ia)所示的化合物或式(Ia)所示化合物的立体异构体、互变异构体、氮氧化物或盐:In some of these embodiments, the present invention provides a compound that is a compound of formula (Ia) or a stereoisomer, tautomer, nitrogen oxide or salt of a compound of formula (Ia):

Figure BDA0002355877140000111
Figure BDA0002355877140000111

其中Q、R1、R2、R3、R4和R5具有如本发明所述的含义。wherein Q, R 1 , R 2 , R 3 , R 4 and R 5 have the meanings as described in the present invention.

其中一些实施方案中,本发明提供一种化合物,其为如式(Ib)所示的化合物或式(Ib)所示化合物的立体异构体、互变异构体、氮氧化物或盐:In some of these embodiments, the present invention provides a compound that is a compound of formula (Ib) or a stereoisomer, tautomer, nitrogen oxide or salt of a compound of formula (Ib):

Figure BDA0002355877140000112
Figure BDA0002355877140000112

其中Q、R1、R2、R3、R4和R5具有如本发明所述的含义。wherein Q, R 1 , R 2 , R 3 , R 4 and R 5 have the meanings as described in the present invention.

其中一些实施方案中,本发明提供一种化合物,其为如式(Ic)所示的化合物或式(Ic)所示化合物的立体异构体、互变异构体、氮氧化物或盐:In some of these embodiments, the present invention provides a compound that is a compound of formula (Ic) or a stereoisomer, tautomer, nitrogen oxide or salt of a compound of formula (Ic):

Figure BDA0002355877140000113
Figure BDA0002355877140000113

其中Q、R1、R2、R3、R4和R5具有如本发明所述的含义。wherein Q, R 1 , R 2 , R 3 , R 4 and R 5 have the meanings as described in the present invention.

另外一些实施方案中,Q为以下子结构式:In other embodiments, Q is the following substructural formula:

Figure BDA0002355877140000114
Figure BDA0002355877140000114

其中Ra和Rb各自独立地为氢、甲基、乙基或环丙基;wherein R a and R b are each independently hydrogen, methyl, ethyl or cyclopropyl;

R1、R2、R3、R4和R5各自独立地为氢、卤素、氰基、羟基、硝基、氨基、羧基、甲基、乙基、正丙基、异丙基、二氟甲基、三氟甲基、甲氧基、乙氧基、二氟甲氧基或三氟甲氧基。R 1 , R 2 , R 3 , R 4 and R 5 are each independently hydrogen, halogen, cyano, hydroxyl, nitro, amino, carboxyl, methyl, ethyl, n-propyl, isopropyl, difluoro Methyl, trifluoromethyl, methoxy, ethoxy, difluoromethoxy or trifluoromethoxy.

本发明优选地为式(Ia)所示的化合物或式(Ia)所示化合物的立体异构体、互变异构体、氮氧化物或盐,例如剂量为150g a.i./ha,该类化合物对马齿苋的苗后防效可达89-100%,相比于本发明的其他类型式(Ib)或式(Ic),具有更优异的防治效果。The present invention is preferably the compound represented by the formula (Ia) or the stereoisomer, tautomer, nitrogen oxide or salt of the compound represented by the formula (Ia), for example, the dosage is 150g a.i./ha, such compounds The post-emergence control effect on purslane can reach 89-100%, and compared with other types of formula (Ib) or formula (Ic) of the present invention, it has more excellent control effect.

其中一些实施方案中,本发明提供一种化合物,其为具有下列之一结构的化合物或具有下列之一结构化合物的立体异构体、互变异构体、氮氧化物或其盐:In some of these embodiments, the present invention provides a compound, which is a compound having one of the following structures or a stereoisomer, tautomer, nitrogen oxide or salt thereof of a compound having one of the following structures:

Figure BDA0002355877140000121
Figure BDA0002355877140000121

Figure BDA0002355877140000131
Figure BDA0002355877140000132
或者
Figure BDA0002355877140000133
Figure BDA0002355877140000131
Figure BDA0002355877140000132
or
Figure BDA0002355877140000133

另一方面,本发明提供一种组合物,包含本发明所述的化合物。In another aspect, the present invention provides a composition comprising the compound of the present invention.

其中一些实施方案中,本发明所述的组合物任选地进一步包含至少一种附加组分。In some of these embodiments, the compositions described herein optionally further comprise at least one additional component.

另外一些实施方案中,本发明所述组合物为除草组合物。In other embodiments, the compositions of the present invention are herbicidal compositions.

另一方面,本发明提供本发明所述化合物或包含本发明所述化合物的组合物在农业中的应用。In another aspect, the present invention provides the use of a compound of the present invention or a composition comprising the compound of the present invention in agriculture.

另一方面,本发明提供本发明所述化合物或包含本发明所述化合物的组合物作为除草剂的用途。In another aspect, the present invention provides the use of a compound of the present invention or a composition comprising the compound of the present invention as a herbicide.

其中一些实施方案中,本发明提供本发明所述化合物或包含本发明所述化合物的组合物作为苗前除草剂的用途。In some of these embodiments, the present invention provides the use of a compound of the present invention or a composition comprising the compound of the present invention as a pre-emergence herbicide.

另外一些实施方案中,本发明提供本发明所述化合物或包含本发明所述化合物的组合物作为苗后除草剂的用途。In other embodiments, the present invention provides the use of a compound of the present invention or a composition comprising a compound of the present invention as a post-emergence herbicide.

进一步地,本发明提供本发明所述化合物或包含本发明所述化合物的组合物在植物病害防治中的应用。Further, the present invention provides the application of the compound of the present invention or the composition comprising the compound of the present invention in the control of plant diseases.

其中一些实施方案中,本发明提供本发明所述化合物或包含本发明所述化合物的组合物用于防治不想要的植物的用途。In some of these embodiments, the present invention provides the use of a compound of the present invention or a composition comprising a compound of the present invention for controlling unwanted plants.

另一方面,本发明提供防治不想要的植物的方法,其特征在于将有效量的本发明所述化合物或包含本发明所述化合物的组合物施用于植物、植物种子、其中或其上生长植物的土壤,或栽培区域。In another aspect, the present invention provides a method for controlling unwanted plants, characterized in that an effective amount of a compound according to the invention or a composition comprising a compound according to the invention is applied to plants, plant seeds, plants growing therein or thereon soil, or cultivation area.

还一方面,本发明提供一种控制有用植物中杂草生长的方法,其包含向杂草所在地苗前施用有效量的发明所述化合物或包含本发明所述化合物的组合物。In yet another aspect, the present invention provides a method of controlling the growth of weeds in useful plants, comprising applying an effective amount of a compound of the present invention or a composition comprising the compound of the present invention to a pre-emergence locus of the weed.

其中一些实施方案中,所述杂草包括阔叶科杂草和禾本科杂草。In some of these embodiments, the weeds include broadleaf weeds and grass weeds.

另外一些实施方案中,所述阔叶科杂草为苘麻、反枝苋、马齿苋或鱧肠。In other embodiments, the broadleaf weed is abalone, amaranth, purslane or snakehead.

另外一些实施方案中,所述禾本科杂草为马唐、稗草、黑麦草或狗尾草。In other embodiments, the grass weed is crabgrass, barnyardgrass, ryegrass, or foxtail.

另外一些实施方案中,所述有用植物包括玉米、水稻、棉花、油菜、大豆或花生。In other embodiments, the useful plants include corn, rice, cotton, canola, soybean, or peanut.

本发明提供的化合物,是一种对杂草更有效、成本更低、毒性更小、对作物安全的新型化合物。The compound provided by the invention is a novel compound which is more effective to weeds, has lower cost, less toxicity and is safe to crops.

本发明化合物的组合物和制剂Compositions and Formulations of Compounds of the Invention

本发明的化合物一般可用作组合物或制剂中的除草剂活性成分,所述组合物或制剂具有至少一种附加组分,所述附加组分选自表面活性剂、固体稀释剂和液体稀释剂、润湿剂、分散剂、乳化剂、增稠剂、崩解剂、防冻剂、消泡剂、防腐剂、稳定剂等等,满足农药使用要求的组分都属于本发明的范围。选择所述制剂或组合物成分,以与所述活性成分的物理特性、施用方式和环境因素(如土壤类型、湿度和温度)相一致。The compounds of the present invention are generally useful as herbicidal active ingredients in compositions or formulations having at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents Agents, wetting agents, dispersing agents, emulsifiers, thickening agents, disintegrating agents, antifreeze agents, defoaming agents, preservatives, stabilizers, etc., the components that meet the requirements of pesticide use all belong to the scope of the present invention. The formulation or composition ingredients are selected to be consistent with the physical properties of the active ingredient, the mode of application and environmental factors such as soil type, humidity and temperature.

有用的制剂包括液体组合物和固体组合物。液体组合物包括溶液(包括乳油)、悬浮液、乳液(包括微乳液和/或悬乳液)等,它们可以任选地被稠化成凝胶。水性液体组合物的一般类型为可溶性浓缩物、悬浮液浓缩物、胶囊悬浮液、浓缩乳液、微乳液和悬乳液。非水性液体组合物的一般类型为乳油、可微乳化的浓缩物、可分散浓缩物和油分散体。Useful formulations include liquid compositions and solid compositions. Liquid compositions include solutions (including emulsifiable concentrates), suspensions, emulsions (including microemulsions and/or suspoemulsions), and the like, which may optionally be thickened into gels. The general types of aqueous liquid compositions are soluble concentrates, suspension concentrates, capsule suspensions, concentrated emulsions, microemulsions and suspoemulsions. The general types of non-aqueous liquid compositions are emulsifiable concentrates, microemulsifiable concentrates, dispersible concentrates and oil dispersions.

固体组合物的一般类型为粉剂、粉末、颗粒、粒料、球粒、锭剂、片剂、填充薄膜(包括种子包衣)等,它们可以是水分散性的(“可润湿的”)或水溶性的。由成膜溶液或可流动的悬浮液形成的膜和包衣尤其可用于种子处理。活性成分可被(微)胶囊包封,并且进一步形成悬浮液或固体制剂;或者可将整个活性成分制剂胶囊包封(或“包覆”)。胶囊包封可以控制或延迟活性成分的释放。可乳化的颗粒结合了乳油制剂和干颗粒制剂两者的优点。高浓度组合物主要用作其它制剂的中间体。The general types of solid compositions are powders, powders, granules, granules, pellets, lozenges, tablets, filled films (including seed coatings), etc., which may be water-dispersible ("wettable") or water-soluble. Films and coatings formed from film-forming solutions or flowable suspensions are particularly useful for seed treatment. The active ingredient can be (micro)encapsulated and further formed into a suspension or solid formulation; or the entire active ingredient formulation can be encapsulated (or "coated"). Encapsulation can control or delay the release of the active ingredient. Emulsifiable granules combine the advantages of both emulsifiable concentrate formulations and dry granule formulations. High concentration compositions are mainly used as intermediates for other formulations.

可喷雾的制剂通常在喷雾之前分散在合适的介质中。将此类液体制剂和固体制剂配制成易于在喷雾介质(通常是水)中稀释的制剂。喷雾体积可以在每公顷约一升至几千升的范围内,但更典型地在每公顷约十升至几百升的范围内。可喷雾的制剂可在水槽中与水或另一种合适的介质混合,用于通过空气或地面施用来处理叶子,或者施用到植物的生长介质中。液体和干制剂可以直接定量加入到滴灌系统中,或者在种植期间定量加入到垄沟中。Sprayable formulations are usually dispersed in a suitable medium before spraying. Such liquid and solid formulations are formulated for ease of dilution in a spray medium, usually water. Spray volumes can range from about one to several thousand liters per hectare, but are more typically in the range of about ten to several hundred liters per hectare. Sprayable formulations can be tank mixed with water or another suitable medium for foliar treatment by air or ground application, or applied to the growing medium of plants. Liquid and dry formulations can be dosed directly into drip irrigation systems or into furrows during planting.

所述制剂通常将包含有效量的活性成分、稀释剂和表面活性剂,总和为按重量计100%。The formulations will generally contain effective amounts of active ingredient, diluent and surfactant, which add up to 100% by weight.

固体稀释剂包括例如粘土例如膨润土、蒙脱石、绿坡缕石和高岭土、石膏、纤维素、二氧化钛、氧化锌、淀粉、糊精、糖(例如乳糖、蔗糖)、硅石、滑石、云母、硅藻土、尿素、碳酸钙、碳酸钠和碳酸氢钠以及硫酸钠。典型的固体稀释剂描述于Watkins等人的Handbook ofInsecticide Dust Diluents and Carriers,第2版,Dorland Books,Caldwell,NewJersey中。Solid diluents include, for example, clays such as bentonite, montmorillonite, attapulgite and kaolin, gypsum, cellulose, titanium dioxide, zinc oxide, starch, dextrin, sugars (eg lactose, sucrose), silica, talc, mica, diatoms Soil, urea, calcium carbonate, sodium carbonate and bicarbonate, and sodium sulfate. Typical solid diluents are described in Watkins et al., Handbook of Insecticide Dust Diluents and Carriers, 2nd Edition, Dorland Books, Caldwell, New Jersey.

液体稀释剂包括例如水、N,N-二甲基烷酰胺(例如N,N-二甲基甲酰胺)、柠檬烯、二甲基亚砜、N-烷基吡咯烷酮(例如N-甲基吡咯烷酮)、乙二醇、三甘醇、丙二醇、双丙二醇、聚丙二醇、碳酸亚丙酯、碳酸亚丁酯、石蜡(例如白矿物油、正链烷烃、异链烷烃)、烷基苯、烷基萘、甘油、三乙酸甘油酯、山梨醇、芳烃、脱芳构化脂族化合物、烷基苯、烷基萘、酮(如环己酮、2-庚酮、异佛尔酮和4-羟基-4-甲基-2-戊酮)、乙酸酯(如乙酸异戊酯、乙酸己酯、乙酸庚酯、乙酸辛酯、乙酸壬酯、乙酸十三烷基酯和乙酸异冰片酯)、其它酯(如烷基化乳酸酯、二元酯和γ-丁内酯)、并且可以是直链的、支链的、饱和的或不饱和的醇(如甲醇、乙醇、正丙醇、异丙醇、正丁醇、异丁醇、正己醇、2-乙基己醇、正辛醇、癸醇、异癸醇、异十八醇、鲸蜡醇、月桂醇、十三烷醇、油醇、环己醇、四氢糠醇、双丙酮醇和苄醇)。液体稀释剂还包括饱和的和不饱和的脂肪酸(通常为C6-C22)的甘油酯,如植物种子和果实的油(例如橄榄油、蓖麻油、亚麻籽油、芝麻油、玉米油、花生油、葵花籽油、葡萄籽油、红花油、棉籽油、豆油、油菜籽油、椰子油和棕榈仁油)、动物源脂肪(例如牛脂、猪脂、猪油、鳕鱼肝油、鱼油),以及它们的混合物。液体稀释剂还包括烷基化(例如甲基化、乙基化、丁基化)的脂肪酸,其中脂肪酸可以通过源自植物和动物的甘油酯的水解获得,并且可通过蒸馏进行纯化。典型的液体稀释剂描述于Marsden的Solvents Guide,第2版,Interscience,New York,1950中。Liquid diluents include, for example, water, N,N-dimethylalkaneamides (eg, N,N-dimethylformamide), limonene, dimethylsulfoxide, N-alkylpyrrolidones (eg, N-methylpyrrolidone) , ethylene glycol, triethylene glycol, propylene glycol, dipropylene glycol, polypropylene glycol, propylene carbonate, butylene carbonate, paraffins (such as white mineral oil, n-paraffins, isoparaffins), alkylbenzenes, alkylnaphthalenes, Glycerin, triacetin, sorbitol, aromatic hydrocarbons, dearomatized aliphatic compounds, alkylbenzenes, alkylnaphthalenes, ketones such as cyclohexanone, 2-heptanone, isophorone and 4-hydroxy-4 - methyl-2-pentanone), acetates (such as isoamyl acetate, hexyl acetate, heptyl acetate, octyl acetate, nonyl acetate, tridecyl acetate and isobornyl acetate), other esters (such as alkylated lactates, dibasic esters, and gamma-butyrolactone), and may be linear, branched, saturated or unsaturated alcohols (such as methanol, ethanol, n-propanol, isopropyl alcohol) Propanol, n-butanol, isobutanol, n-hexanol, 2-ethylhexanol, n-octanol, decyl alcohol, isodecyl alcohol, isostearyl alcohol, cetyl alcohol, lauryl alcohol, tridecyl alcohol, oil alcohol, cyclohexanol, tetrahydrofurfuryl alcohol, diacetone alcohol and benzyl alcohol). Liquid diluents also include glycerides of saturated and unsaturated fatty acids (usually C6 - C22 ), such as oils of plant seeds and fruits (eg olive oil, castor oil, linseed oil, sesame oil, corn oil, peanut oil , sunflower oil, grapeseed oil, safflower oil, cottonseed oil, soybean oil, rapeseed oil, coconut oil, and palm kernel oil), fats of animal origin (such as tallow, lard, lard, cod liver oil, fish oil), and their mixture. Liquid diluents also include alkylated (eg, methylated, ethylated, butylated) fatty acids, which fatty acids can be obtained by hydrolysis of glycerides derived from plants and animals, and can be purified by distillation. Typical liquid diluents are described in Marsden's Solvents Guide, 2nd Edition, Interscience, New York, 1950.

本发明的固体组合物和液体组合物通常包含一种或多种表面活性剂。当加进液体中时,表面活性剂(也称为“具有表面活性的试剂”)通常改变,最通常降低液体的表面张力。根据表面活性剂分子中的亲水基团和亲脂基团的性质,表面活性剂可用作润湿剂、分散剂、乳化剂或消泡剂。The solid and liquid compositions of the present invention typically contain one or more surfactants. When added to a liquid, surfactants (also referred to as "surface-active agents") typically change, most typically lower the surface tension of the liquid. Depending on the nature of the hydrophilic and lipophilic groups in the surfactant molecule, surfactants can be used as wetting agents, dispersing agents, emulsifiers or defoaming agents.

表面活性剂可分为非离子表面活性剂、阴离子表面活性剂或阳离子表面活性剂。可用作本发明的组合物的非离子表面活性剂包括但不限于:醇烷氧基化物,如基于天然醇和合成醇(其为支链的或直链的)并且由醇和环氧乙烷、环氧丙烷、环氧丁烷或它们的混合物制备的醇烷氧基化物;胺乙氧基化、链烷醇酰胺和乙氧基化的链烷醇酰胺;烷氧基化的甘油三酯,如乙氧基化的大豆、蓖麻和油菜籽油;烷基苯酚烷氧基化物,如辛基苯酚乙氧基化、壬基苯酚乙氧基化、二壬基苯酚乙氧基化物和十二烷基苯酚乙氧基化物(由苯酚和环氧乙烷、环氧丙烷、环氧丁烷或它们的混合物制备);由环氧乙烷或环氧丙烷和反向嵌段聚合物制备的嵌段聚合物,其中所述末端嵌段由环氧丙烷制备;乙氧基化的脂肪酸;乙氧基化的脂肪族酯和油;乙氧基化的甲基酯;乙氧基化的三苯乙烯基苯酚(包括由环氧乙烷、环氧丙烷、环氧丁烷或它们的混合物制备的那些);脂肪酸酯、甘油酯、羊毛脂基的衍生物、多乙氧基化的酯,如多乙氧基化的脱水山梨糖醇脂肪酸酯、多乙氧基化的山梨醇脂肪酸酯和多乙氧基化甘油脂肪酸酯;其它脱水山梨糖醇衍生物,如脱水山梨糖醇酯;聚合表面活性剂如无规共聚物、嵌段共聚物、醇酸PEG(聚乙二醇)树脂、接枝或梳妆聚合物和星型聚合物;聚乙二醇(PEG);聚乙二醇脂肪酸酯;硅酮基的表面活性剂;以及糖衍生物,如蔗糖酯、烷基聚葡萄糖苷和烷基多糖。Surfactants can be classified as nonionic surfactants, anionic surfactants or cationic surfactants. Nonionic surfactants useful in the compositions of the present invention include, but are not limited to, alcohol alkoxylates, such as those based on natural alcohols and synthetic alcohols (which are branched or linear) and composed of alcohols and ethylene oxide, Alcohol alkoxylates prepared from propylene oxide, butylene oxide or mixtures thereof; amine ethoxylates, alkanolamides and ethoxylated alkanolamides; alkoxylated triglycerides, such as ethoxylated soybean, castor and rapeseed oils; alkylphenol alkoxylates such as octylphenol ethoxylate, nonylphenol ethoxylate, dinonylphenol ethoxylate and ten Dialkylphenol ethoxylates (prepared from phenol and ethylene oxide, propylene oxide, butylene oxide, or mixtures thereof); prepared from ethylene oxide or propylene oxide and reverse block polymers Block polymers wherein the end blocks are prepared from propylene oxide; ethoxylated fatty acids; ethoxylated fatty esters and oils; ethoxylated methyl esters; ethoxylated triglycerides Styryl phenols (including those prepared from ethylene oxide, propylene oxide, butylene oxide, or mixtures thereof); fatty acid esters, glycerides, lanolin-based derivatives, polyethoxylated esters , such as polyethoxylated sorbitan fatty acid esters, polyethoxylated sorbitan fatty acid esters and polyethoxylated glycerol fatty acid esters; other sorbitan derivatives such as sorbitan Alcohol esters; polymeric surfactants such as random copolymers, block copolymers, alkyd PEG (polyethylene glycol) resins, graft or cosmetic polymers and star polymers; polyethylene glycol (PEG); poly Glycol fatty acid esters; silicone-based surfactants; and sugar derivatives such as sucrose esters, alkyl polyglucosides, and alkyl polysaccharides.

可用的阴离子表面活性剂包括但不限于:烷基芳基磺酸和它们的盐;羧化的醇或烷基苯酚乙氧基化物;二苯基磺酸酯衍生物;木质素和木质素衍生物,如木质素磺酸盐;马来酸或琥珀酸或它们的酸酐;烯烃磺酸酯;磷酸酯,诸如醇烷氧基化物的磷酸酯、烷基酚烷氧基化物的磷酸酯和苯乙烯基苯酚乙氧基化物的磷酸酯;蛋白质基的表面活性剂;肌氨酸衍生物;苯乙烯基苯酚醚硫酸盐;油和脂肪酸的硫酸盐和磺酸盐;乙氧基化烷基酚的硫酸盐和磺酸盐;醇的硫酸盐;乙氧基化醇的硫酸盐;胺和酰胺的磺酸盐,如N,N-烷基牛磺酸盐;苯、异丙基苯、甲苯、二甲苯以及十二烷基苯和十三烷基苯的磺酸盐;缩聚萘的磺酸盐;萘和烷基萘的磺酸盐;石油馏分的磺酸盐;磺基琥珀酰胺酸盐;以及磺基琥珀酸盐和它们的衍生物,如二烷基磺基琥珀酸盐。Useful anionic surfactants include, but are not limited to: alkylarylsulfonic acids and their salts; carboxylated alcohol or alkylphenol ethoxylates; diphenylsulfonate derivatives; lignin and lignin derivatives sulfonates, such as lignosulfonates; maleic or succinic acids or their anhydrides; olefin sulfonates; phosphates, such as phosphates of alcohol alkoxylates, phosphates of alkylphenol alkoxylates, and benzene Phosphate esters of vinylphenol ethoxylates; protein-based surfactants; sarcosine derivatives; styrylphenol ether sulfates; sulfates and sulfonates of oils and fatty acids; ethoxylated alkylphenols Sulfates and sulfonates of alcohols; sulfates of alcohols; sulfates of ethoxylated alcohols; sulfonates of amines and amides, such as N,N-alkyl taurates; benzene, cumene, toluene , xylene and sulfonates of dodecylbenzene and tridecylbenzene; sulfonates of polycondensed naphthalenes; sulfonates of naphthalene and alkylnaphthalenes; sulfonates of petroleum fractions; sulfosuccinamates ; and sulfosuccinates and their derivatives, such as dialkyl sulfosuccinates.

可用的阳离子表面活性剂包括但不限于:酰胺和乙氧基化酰胺;胺,如N-烷基丙二胺、三亚丙基三胺和二亚丙基四胺,以及乙氧基化胺、乙氧基化二胺和丙氧基化胺(由胺和环氧乙烷、环氧丙烷、环氧丁烷或它们的混合物制备);胺盐,如胺乙酸盐和二胺盐;季铵盐,如季盐、乙氧基化季盐和二季盐;以及胺氧化物,如烷基二甲基胺氧化物和二-(2-羟基乙基)-烷基胺氧化物。Useful cationic surfactants include, but are not limited to: amides and ethoxylated amides; amines such as N-alkylpropylenediamines, tripropylenetriamines, and dipropylenetetramines, and ethoxylated amines, Ethoxylated diamines and propoxylated amines (prepared from amines and ethylene oxide, propylene oxide, butylene oxide or mixtures thereof); amine salts such as amine acetate and diamine salts; quaternary Ammonium salts, such as quaternary, ethoxylated, and diquaternary salts; and amine oxides, such as alkyldimethylamine oxides and bis-(2-hydroxyethyl)-alkylamine oxides.

还可用于本发明的组合物的是非离子表面活性剂和阴离子表面活性剂的混合物,或非离子表面活性剂和阳离子表面活性剂的混合物。非离子、阴离子和阳离子表面活性剂以及它们被推荐的用途公开于多个已公布的参考文献中,包括由McCutcheon’s Division,The Manufacturing Confectioner Publishing Co.出版的McCutcheon′s Emulsifiersand Detergents,北美和国际年鉴版;Sisely和Wood的Encyclopedia of Surface ActiveAgents,Chemical Publ.Co.,Inc.,New York,1964;以及A.S.Davidson和B.Milwidsky的Synthetic Detergents,第七版,John Wiley and Sons,New York,1987。Also useful in the compositions of the present invention are mixtures of nonionic and anionic surfactants, or mixtures of nonionic and cationic surfactants. Nonionic, anionic and cationic surfactants and their suggested uses are disclosed in various published references, including McCutcheon's Emulsifiers and Detergents, North American and International Yearbook editions, published by McCutcheon's Division, The Manufacturing Confectioner Publishing Co. ; Sisely and Wood, Encyclopedia of Surface ActiveAgents, Chemical Publ. Co., Inc., New York, 1964; and A.S. Davidson and B. Milwidsky, Synthetic Detergents, Seventh Edition, John Wiley and Sons, New York, 1987.

本发明的组合物还可包含本领域技术人员已知为辅助制剂的制剂助剂和添加剂(其中一些也可被认为是起到固体稀释剂、液体稀释剂或表面活性剂作用的)。此类制剂助剂和添加剂可控制:pH(缓冲剂)、加工过程中的起泡(消泡剂如聚有机硅氧烷)、活性成分的沉降(悬浮剂)、粘度(触变增稠剂)、容器内的微生物生长(抗微生物剂)、产品冷冻(防冻剂)、颜色(染料/颜料分散体)、洗脱(成膜剂或粘合剂)、蒸发(防蒸发剂)、以及其它制剂属性。成膜剂包括例如聚乙酸乙烯酯、聚乙酸乙烯酯共聚物、聚乙烯吡咯烷酮-乙酸乙烯酯共聚物、聚乙烯醇、聚乙烯醇共聚物和蜡。制剂助剂和添加剂的实例包括由McCutcheon’sDivision,The Manufacturing Confectioner Publishing Co.出版的McCutcheon’sVolume 2:Functional Materials,北美和国际年鉴版;以及PCT公布WO03/024222中列出的那些。The compositions of the present invention may also contain formulation aids and additives known to those skilled in the art as adjuvants (some of which may also be considered to function as solid diluents, liquid diluents or surfactants). Such formulation aids and additives control: pH (buffers), foaming during processing (defoamers such as polyorganosiloxanes), settling of active ingredients (suspending agents), viscosity (thixotropic thickeners) ), microbial growth in containers (anti-microbial agents), product freezing (anti-freeze agents), color (dye/pigment dispersions), elution (film formers or binders), evaporation (anti-evaporation agents), and others Formulation properties. Film formers include, for example, polyvinyl acetate, polyvinyl acetate copolymers, polyvinylpyrrolidone-vinyl acetate copolymers, polyvinyl alcohol, polyvinyl alcohol copolymers, and waxes. Examples of formulation aids and additives include those listed in McCutcheon's Volume 2: Functional Materials, North American and International Yearbook Editions, published by McCutcheon's Division, The Manufacturing Confectioner Publishing Co.; and PCT Publication WO03/024222.

通常通过将活性成分溶于溶剂中或通过在液体稀释剂或干稀释剂中研磨活性成分将本发明的化合物和任何其它的活性成分掺入到本发明的组合物中。可通过简单地混合所述成分来制备溶液,包括乳油。如果用作乳油的液体组合物的溶剂是与水不混溶的,则通常加入乳化剂使含有活性成分的溶剂在用水稀释时发生乳化。可使用介质磨来湿研磨粒径为至多2,000μm的活性成分浆液,以获得平均直径低于3μm的颗粒。水性浆液可以制备为成品悬浮液浓缩物(参见例如U.S.3,060,084)或通过喷雾干燥而进一步加工形成水分散性的颗粒。干制剂通常需要干研磨步骤,其产生在2μm至10μm范围内的平均粒径。粉剂和粉末可以通过混合,并且通常通过研磨(例如用锤磨机或流能磨)来制备。可通过将活性物质喷雾在预成形颗粒载体上或通过附聚技术来制备颗粒和粒料。参见Browning的“Agglomeration”(Chemical Engineering,1967年12月4日,第147-48页;Perry的ChemicalEngineer’s Handbook,第4版,McGraw-Hill,New York,1963,第8-57页及其后页和WO91/13546。粒料可以如U.S.4,172,714中所述来制备。水分散性的和水溶性的颗粒可以如U.S.4,144,050、U.S.3,920,442和DE.3,246,493中所提出的来制备。片剂可以如U.S.5,180,587、U.S.5,232,701和U.S.5,208,030中所提出的来制备。膜可以如GB2,095,558和U.S.3,299,566中所提出的来制备。The compounds of the present invention and any other active ingredients are generally incorporated into the compositions of the present invention by dissolving the active ingredient in a solvent or by grinding the active ingredient in a liquid or dry diluent. Solutions, including emulsifiable concentrates, can be prepared by simply mixing the ingredients. If the solvent of the liquid composition used as an emulsifiable concentrate is immiscible with water, an emulsifier is usually added to emulsify the solvent containing the active ingredient upon dilution with water. A media mill can be used to wet-mill active ingredient slurries having a particle size of up to 2,000 μm to obtain particles with an average diameter of less than 3 μm. Aqueous slurries can be prepared as finished suspension concentrates (see, eg, U.S. 3,060,084) or further processed by spray drying to form water-dispersible particles. Dry formulations typically require a dry milling step, which yields an average particle size in the range of 2 μm to 10 μm. Dusts and powders can be prepared by mixing, and usually by grinding (eg, with a hammer mill or fluid energy mill). Granules and pellets can be prepared by spraying the active material onto preformed granular carriers or by agglomeration techniques. See Browning, "Agglomeration" (Chemical Engineering, December 4, 1967, pp. 147-48; Perry's Chemical Engineer's Handbook, 4th edition, McGraw-Hill, New York, 1963, pp. 8-57 et seq. and WO91/13546. Granules can be prepared as described in U.S. 4,172,714. Water-dispersible and water-soluble granules can be prepared as proposed in U.S. 4,144,050, U.S. 3,920,442 and DE.3,246,493. Tablets can be prepared as described in U.S. 5,180,587 , U.S. 5,232,701 and U.S. 5,208,030. Membranes can be prepared as proposed in GB 2,095,558 and U.S. 3,299,566.

与制剂领域相关的其他信息,参见T.S.Woods的“The Formulator’s Toolbox-Product Forms for Modern Agriculture”,Pesticide Chemistry and Bioscience,TheFood-Environment Challenge,T.Brooks和T.R.Roberts编辑,Proceedings of the 9thInternational Congress on PesticideChemistry,The Royal Society of Chemistry,Cambridge,1999,第120-133页。还可参见U.S.3,235,361第6栏,第16行至第7栏,第19行和实施例10-41;U.S3,309,192第5栏,第43行至第7栏,第62行和实施例8、12、15、39、41、52、53、58、132、138-140、162-164、166、167和169-182;U.S.2,891,855第3栏,第66行至第5栏,第17行和实施例1-4;Klingman的Weed Control as a Science,John Wiley and Sons,Inc.,New York,1961,第81-96页;Hance等人的Weed Control Handbook,第8版,BlackwellScientific Publications,Oxford,1989;以及Developments in formulationtechnology,PJB Publications,Richmond,UK,2000。For additional information related to the formulation field, see "The Formulator's Toolbox-Product Forms for Modern Agriculture" by T.S. Woods, Pesticide Chemistry and Bioscience, The Food-Environment Challenge, edited by T. Brooks and T.R. Roberts, Proceedings of the 9th International Congress on Pesticide Chemistry, The Royal Society of Chemistry, Cambridge, 1999, pp. 120-133. See also U.S. 3,235,361 column 6, lines 16 to 7, line 19 and Examples 10-41; U.S. 3,309,192 column 5, lines 43 to 7, line 62 and examples 8, 12, 15, 39, 41, 52, 53, 58, 132, 138-140, 162-164, 166, 167, and 169-182; U.S. 2,891,855 col. 3, lines 66-5, col. 17 Rows and Examples 1-4; Klingman's Weed Control as a Science, John Wiley and Sons, Inc., New York, 1961, pp. 81-96; Hance et al., Weed Control Handbook, 8th Edition, Blackwell Scientific Publications, Oxford, 1989; and Developments in formulation technology, PJB Publications, Richmond, UK, 2000.

本发明化合物的应用Use of the compounds of the present invention

本发明除草剂可通过给植物喷雾、施加到土壤中、施加到水表面上来使用。适当地确定活性组分的用量以满足应用目的。根据该目的来适当地确定活性组分的含量。The herbicides of the present invention can be used by spraying plants, applying to soil, to water surfaces. The amount of active ingredient is appropriately determined to suit the purpose of application. The content of the active ingredient is appropriately determined according to the purpose.

本发明化合物的用量根据所用化合物的种类、目标杂草、杂草出现的趋势、环境条件和除草剂的种类等。当本发明除草剂自身的形式例如以粉末或颗粒的形式使用时,其用量适当地选取为1g-50kg、优选10g-10kg/1公顷的活性组分。当本发明的除草剂以液体形式例如以可乳化的浓缩物、可湿性粉剂或可流动制剂的形式使用时,其用量适当地选取为0.1-50,000ppm、优选10-10,000ppm。The amount of the compound of the present invention depends on the type of the compound used, the target weed, the tendency of weed emergence, the environmental conditions, the type of herbicide, and the like. When the herbicide of the present invention is used in its own form, eg, in the form of powder or granules, the amount thereof is appropriately selected to be 1 g to 50 kg, preferably 10 g to 10 kg per 1 hectare of active ingredient. When the herbicide of the present invention is used in a liquid form such as an emulsifiable concentrate, a wettable powder or a flowable formulation, the amount thereof is appropriately selected to be 0.1-50,000 ppm, preferably 10-10,000 ppm.

本发明提供了一种用于控制有用植物的作物中的杂草的方法,该方法包括向所述杂草或向所述杂草的场所或向所述有用植物或向所述有用植物的场所施用本发明的化合物或组合物。The present invention provides a method for controlling weeds in crops of useful plants, the method comprising directing the weeds or to the locus of the weeds or to the useful plants or to the locus of the useful plants A compound or composition of the present invention is administered.

本发明还提供了一种选择性控制有用植物的作物中的草和/或杂草的方法,该方法包括向有用植物或其场所或向栽培区域施用除草有效量的具有如式(I)、式(Ia)、式(Ib)或式(Ic)所示的化合物。The present invention also provides a method for selectively controlling grasses and/or weeds in crops of useful plants, the method comprising applying to the useful plants or their locus or to a cultivation area a herbicidally effective amount of a herbicide having formula (I), A compound represented by formula (Ia), formula (Ib) or formula (Ic).

术语“除草剂”意指一种控制或改变植物生长的化合物。术语“除草有效量”意指能够产生控制或改变植物生长效果的这样一种化合物或此类化合物的组合物的量。控制或者改变的效果包括所有自然发展的偏离,例如,杀害、延迟、叶灼伤、白化病、矮化病等。术语“植物”指的是植物的所有有形部分,包括种子、幼苗、幼株、根、块茎、茎、秆、叶和果实。术语“所在地”旨在包括土壤、种子以及幼苗,连同已经建立的植物(established vegetation)并且不仅包括杂草可能已经生长的区域,而且还包括杂草尚未出现的区域,并且还包括关于有用植物作物的种植的区域。“种植的区域”包括作物植物已经在其上生长的土地,以及打算用来种植此类作物植物的土地。如在此使用的术语“杂草”意指任何不希望的植物,并且因此不仅包括如下所述的重要的农艺杂草,而且还包括自生作物植物。The term "herbicide" means a compound that controls or alters the growth of plants. The term "herbicidally effective amount" means an amount of such a compound or a combination of such compounds capable of producing the effect of controlling or altering plant growth. Controlling or altering effects include all deviations from natural development, eg, killing, delaying, leaf burn, albinism, dwarfism, and the like. The term "plant" refers to all tangible parts of a plant, including seeds, seedlings, young plants, roots, tubers, stems, stalks, leaves, and fruits. The term "locus" is intended to include soil, seeds and seedlings, as well as established vegetation and includes not only areas where weeds may have grown, but also areas where weeds have not yet emerged, and also includes information on crops of useful plants planting area. "Cultivated area" includes land on which crop plants have grown, as well as land intended to be used to grow such crop plants. The term "weed" as used herein means any unwanted plant, and thus includes not only important agronomic weeds as described below, but also volunteer crop plants.

可能使用了根据本发明的组合物的有用植物作物包括但不限于多年生作物,例如柑橘类水果、葡萄树、坚果、油棕榈、橄榄、梨果类水果、核果及橡胶,以及一年生可耕作物,例如谷类(如大麦和小麦)、棉花、油菜、玉米、水稻、大豆、甜菜、甘蔗、向日葵、观赏植物、柳枝稷、草皮以及蔬菜,尤其是谷类、玉米以及大豆。Useful plant crops for which the compositions according to the present invention may be used include, but are not limited to, perennial crops such as citrus fruits, vines, nuts, oil palm, olives, pome fruits, stone fruits and rubber, and annual crops, For example cereals (eg barley and wheat), cotton, canola, corn, rice, soybeans, sugar beets, sugar cane, sunflowers, ornamentals, switchgrass, turf and vegetables, especially cereals, corn and soybeans.

要控制的草和杂草既可以是单子叶的物种,例如剪股颖属、看麦娘属、燕麦属、臂形草属、雀麦属、蒺藜草属、莎草属、马唐属、稗属、野黍属、黑麦草属、雨久花属、黍属、早熟禾属、筒轴茅属、慈姑属、藨草属、狗尾草属、黄花稔属和高粱属,也可以是双子叶的物种,例如白麻属、苋属、藜属、菊属、大戟属、拉拉藤属、番薯属、地肤属、旱金莲属、蓼属植物、黄花稔属、白芥属、茄属、繁缕属、婆婆纳属、堇菜属和苍耳属。The grasses and weeds to be controlled can be either monocotyledonous species, such as Prunus, Avena, Avena, Brachiaria, Brome, Tribulus, Cyperus, Crabata, Barnyardgrass, Mimia, Ryegrass, Plumbago, Milletium, Poa, Cylindrica, Cinnamon, Thorngrass, Setaria, Phyllostachys, and Sorghum, and may also be dicotyledonous Species such as Acanthus, Amaranth, Chenopodium, Chrysanthemum, Euphorbia, Lara, Ipomoea, Kochia, Nasturtium, Polygonum, Rhizoma, Mustard, Solanum Genus, chickweed, mother-in-law, violet and cocklebur.

本发明化合物可示出对重要农作物的耐受性,所述农作物包括但不限于苜蓿、大麦、棉花、小麦、油菜、糖用甜菜、玉米(玉蜀黍)、高粱、大豆、稻、燕麦、花生、蔬菜、番茄、马铃薯、多年生种植作物包括咖啡、可可、油棕、橡胶、甘蔗、柑橘、葡萄、果树、坚果树、香蕉、车前草、菠萝、啤酒花、茶和森林诸如按树和针叶树(例如火炬松)、以及草皮物类(例如草地早熟禾、圣奥古斯丁草(St.Augustine grass)、Kentucky牛毛草和狗牙根草)。The compounds of the present invention may show tolerance to important crops including, but not limited to, alfalfa, barley, cotton, wheat, canola, sugar beet, corn (maize), sorghum, soybean, rice, oat, peanut, Vegetables, tomatoes, potatoes, perennial crops including coffee, cocoa, oil palm, rubber, sugar cane, citrus, grapes, fruit trees, nut trees, bananas, plantains, pineapples, hops, tea and forests such as arbor and conifers (e.g. loblolly pine), and turf species (eg, bluegrass, St. Augustine grass, Kentucky oxhair, and bermudagrass).

如果需要的话,根据本发明的具有如式(I)、式(Ia)、式(Ib)或式(Ic)所示的化合物也可以与其他活性成分,例如其他除草剂和/或杀昆虫剂和/或杀螨剂和/或杀线虫剂和/或杀软体动物剂和/或杀真菌剂和/或植物生长调节剂组合使用。这些混合物、以及这些混合物的用以控制杂草和/或不希望的植物的生长的用途又形成了本发明的另一些方面。为避免疑问,本发明的混合物也包括两种或更多种不同的具有如式(I)、式(Ia)、式(Ib)或式(Ic)所示的化合物的混合物。具体地,本发明还涉及一种本发明的组合物,该组合物除如式(I)、式(Ia)、式(Ib)或式(Ic)所示的化合物之外包含至少一种另外的除草剂。If desired, the compounds of formula (I), formula (Ia), formula (Ib) or formula (Ic) according to the present invention may also be combined with other active ingredients such as other herbicides and/or insecticides and/or acaricides and/or nematicides and/or molluscicides and/or fungicides and/or plant growth regulators. These mixtures, and the use of these mixtures to control the growth of weeds and/or unwanted plants, form yet other aspects of the present invention. For the avoidance of doubt, mixtures of the present invention also include mixtures of two or more different compounds of formula (I), formula (Ia), formula (Ib) or formula (Ic). In particular, the present invention also relates to a composition of the present invention comprising, in addition to a compound represented by formula (I), formula (Ia), formula (Ib) or formula (Ic), at least one additional of herbicides.

一般合成过程General synthetic procedure

在本说明书中,如果在化学名称和化学结构间存在任何差异,结构是占优的。一般地,本发明的化合物可以通过本发明所描述的方法制备得到,除非有进一步的说明。In this specification, if there is any difference between chemical name and chemical structure, the structure will prevail. In general, the compounds of the present invention can be prepared by the methods described herein unless otherwise indicated.

本发明核磁共振氢谱的测试条件是:室温条件下,布鲁克(Bruker)400MHz或600MHz的核磁仪,以CDC13,d6-DMSO,CD3OD或d6-丙酮为溶剂(报导以ppm为单位),用TMS(0ppm)或氯仿(7.26ppm)作为参照标准。当出现多重峰的时候,将使用下面的缩写:s(singlet,单峰),d(doublet,双峰),t(triplet,三重峰),q(quartet,四重峰),m(multiplet,多重峰),br(broadened,宽峰),dd(doublet of doublets,双二重峰),dt(doublet of triplets,双三重峰)。偶合常数,用赫兹(Hz)表示。The test conditions of the hydrogen nuclear magnetic resonance spectrum of the present invention are: under room temperature conditions, Bruker (Bruker) 400MHz or 600MHz nuclear magnetic instrument, with CDC1 3 , d 6 -DMSO, CD 3 OD or d 6 -acetone as solvent (reported in ppm as units), with TMS (0 ppm) or chloroform (7.26 ppm) as the reference standard. When multiplets are present, the following abbreviations are used: s (singlet, singlet), d (doublet, doublet), t (triplet, triplet), q (quartet, quartet), m (multiplet, multiplet), br (broadened, broad peak), dd (doublet of doublets, double doublet), dt (doublet of triplets, double triplet). Coupling constant, expressed in Hertz (Hz).

本发明所用质谱分析方法为:使用Agilent 1260HPLC;Agilent 6120ESI。The mass spectrometry analysis method used in the present invention is: using Agilent 1260HPLC; Agilent 6120ESI.

A相:水(含0.1%甲酸);B相:乙腈(含0.1%甲酸)。Phase A: water (containing 0.1% formic acid); phase B: acetonitrile (containing 0.1% formic acid).

梯度洗脱:0-3min,5-100%B;3-6min,100%B。Gradient elution: 0-3 min, 5-100% B; 3-6 min, 100% B.

流速:0.6mL/min。Flow rate: 0.6 mL/min.

检测波长:254nm。Detection wavelength: 254nm.

MS参数:ESI正扫描,碰撞诱导电离:70V。MS parameters: ESI positive scan, collision induced ionization: 70V.

干燥氮气:12L/min,雾化气压力:40psi,气体温度:350℃。Dry nitrogen: 12 L/min, atomizing gas pressure: 40 psi, gas temperature: 350°C.

取适量样品,溶于0.5mL甲醇,进样,在正ESI模式下进行一级MS全扫描得到准分子离子峰[M+H]+读数。Take an appropriate amount of sample, dissolve it in 0.5 mL of methanol, inject the sample, and perform a first-level MS full scan in positive ESI mode to obtain the quasi-molecular ion peak [M+H] + reading.

下面的简写词释义贯穿本发明:The following abbreviations are defined throughout this invention:

DMF:N,N-二甲基甲酰胺,二甲基甲酰胺DMF: N,N-Dimethylformamide, Dimethylformamide

MeOH:甲醇MeOH: methanol

Et3N:三乙胺Et 3 N: triethylamine

EtOAc:乙酸乙酯EtOAc: ethyl acetate

PE或Petroleum ether:石油醚PE or Petroleum ether: Petroleum ether

TEA:三乙醇胺TEA: Triethanolamine

下面的合成方案和实施例用于进一步举例说明本发明的内容。The following synthetic schemes and examples serve to further illustrate the content of the present invention.

合成方案Synthetic scheme

合成方案一Synthesis scheme one

Figure BDA0002355877140000181
Figure BDA0002355877140000181

化合物D可以通过合成方案一制备得到,其中R1、R2、R3、R4和R5具有如本发明所述的含义。化合物A与酰氯(如草酰氯)在60℃-100℃发生卤代反应,得到化合物B;化合物B与1,3-环己二酮在0℃-35℃发生酯化反应,得到化合物C;化合物C与三甲基氰硅烷在10℃-40℃发生Fries重排反应,得到目标化合物D。Compound D can be prepared by Synthetic Scheme 1, wherein R 1 , R 2 , R 3 , R 4 and R 5 have the meanings as described in the present invention. Compound A undergoes halogenation reaction with acid chloride (such as oxalyl chloride) at 60°C-100°C to obtain compound B; compound B undergoes esterification reaction with 1,3-cyclohexanedione at 0°C-35°C to obtain compound C; Compound C and trimethylsilyl cyanide undergo Fries rearrangement reaction at 10°C-40°C to obtain target compound D.

合成方案二Synthesis scheme two

Figure BDA0002355877140000191
Figure BDA0002355877140000191

化合物F可以通过合成方案二制备得到,其中Ra、Rb、R1、R2、R3、R4和R5具有如本发明所述的含义。化合物B与任选取代地羟基吡唑在0℃-35℃发生酯化反应,得到化合物E;化合物E与三甲基氰硅烷在10℃-40℃发生Fries重排反应,得到目标化合物F。Compound F can be prepared by synthetic scheme II, wherein R a , R b , R 1 , R 2 , R 3 , R 4 and R 5 have the meanings as described in the present invention. Compound B undergoes esterification reaction with optionally substituted hydroxypyrazole at 0°C-35°C to obtain compound E; compound E undergoes Fries rearrangement reaction with trimethylsilyl cyanide at 10°C-40°C to obtain target compound F.

实施例Example

实施例1 2-(5-(2-氯-4-(三氟甲基)苯氧基)-2-硝基苯甲酰基)-3-羟基环己-2-烯酮Example 1 2-(5-(2-Chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoyl)-3-hydroxycyclohex-2-enone

Figure BDA0002355877140000192
Figure BDA0002355877140000192

步骤1:5-(2-氯-4-(三氟甲基)苯氧基)-2-硝基苯甲酰氯的合成Step 1: Synthesis of 5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoyl chloride

Figure BDA0002355877140000193
Figure BDA0002355877140000193

将三氟羧草醚(600mg,1.66mmol)溶于超干二氯甲烷(10mL),-5℃下冷却,10min后,向该反应液中加入草酰氯(2.11g,16.59mmol),最后加入5滴N,N-二甲基甲酰胺,室温反应3h,然后减压蒸馏除去溶剂,得到淡黄色粘稠液体600mg,收率95%。Acifluorfen (600 mg, 1.66 mmol) was dissolved in ultra-dry dichloromethane (10 mL), cooled at -5 °C, after 10 min, oxalyl chloride (2.11 g, 16.59 mmol) was added to the reaction solution, and finally added 5 drops of N,N-dimethylformamide were reacted at room temperature for 3 hours, and then the solvent was distilled off under reduced pressure to obtain 600 mg of a light yellow viscous liquid with a yield of 95%.

步骤2:3-氧代环己-1-烯-1-基5-(2-氯-4-(三氟甲基)苯氧基)-2-硝基苯甲酸酯的合成Step 2: Synthesis of 3-oxocyclohex-1-en-1-yl 5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoate

Figure BDA0002355877140000194
Figure BDA0002355877140000194

将1,3-环己二酮(212mg,1.89mmol)溶于超干二氯甲烷(20mL),然后向反应液中加入三乙胺(319mg,3.16mmol),-5℃下冷却,10min后,向该反应液中加入5-(2-氯-4-(三氟甲基)苯氧基)-2-硝基苯甲酰氯(600mg,1.58mmol)的二氯甲烷(10mL)溶液,室温反应4h,TLC监测原料反应完。向反应液中加入饱和碳酸氢钠溶液(100mL),二氯甲烷萃取(50mL×3),合并有机相,无水Na2SO4干燥,过滤,二氯甲烷洗涤,柱层析分离(洗脱剂:PE/EtOAc(v/v)=20/3),得到棕色油状液体560mg,收率78%。Dissolve 1,3-cyclohexanedione (212mg, 1.89mmol) in ultra-dry dichloromethane (20mL), then add triethylamine (319mg, 3.16mmol) to the reaction solution, cool at -5°C, after 10min , a solution of 5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoyl chloride (600 mg, 1.58 mmol) in dichloromethane (10 mL) was added to the reaction solution at room temperature. The reaction was completed for 4h, and the reaction of the raw materials was monitored by TLC. Saturated sodium bicarbonate solution (100 mL) was added to the reaction solution, extracted with dichloromethane (50 mL×3), the organic phases were combined, dried over anhydrous Na 2 SO 4 , filtered, washed with dichloromethane, and separated by column chromatography (eluting Agent: PE/EtOAc (v/v)=20/3) to obtain 560 mg of brown oily liquid, yield 78%.

MS-ESI:m/z 478.0[M+Na]+.MS-ESI: m/z 478.0[M+Na] + .

步骤3:2-(5-(2-氯-4-(三氟甲基)苯氧基)-2-硝基苯甲酰基)-3-羟基环己-2-烯酮的合成Step 3: Synthesis of 2-(5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoyl)-3-hydroxycyclohex-2-enone

Figure BDA0002355877140000201
Figure BDA0002355877140000201

将3-氧代环己-1-烯-1-基5-(2-氯-4-(三氟甲基)苯氧基)-2-硝基苯甲酸酯(560mg,1.23mmol)溶于超干乙腈(20mL),然后向反应液中加入三乙胺(249mg,2.46mmol),最后向该反应液中加入三甲基氰硅烷(12mg,0.12mmol),室温反应。6h后TLC监测原料反应完。将反应减压蒸馏除去溶剂,用二氯甲烷萃取(50mL×3),水洗(50mL),合并有机相,无水Na2SO4干燥,过滤,二氯甲烷洗涤(10mL),柱层析分离(洗脱剂:DCM/MeOH(v/v)=100/1),得到黄色固体248mg,收率44%。3-Oxocyclohex-1-en-1-yl 5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoate (560 mg, 1.23 mmol) was dissolved In ultra-dry acetonitrile (20 mL), triethylamine (249 mg, 2.46 mmol) was added to the reaction solution, and trimethylsilyl cyanide (12 mg, 0.12 mmol) was finally added to the reaction solution, and the reaction was carried out at room temperature. After 6h, the reaction of the raw materials was monitored by TLC. The reaction was evaporated under reduced pressure to remove the solvent, extracted with dichloromethane (50 mL×3), washed with water (50 mL), combined the organic phases, dried over anhydrous Na 2 SO 4 , filtered, washed with dichloromethane (10 mL), and separated by column chromatography (eluent: DCM/MeOH (v/v)=100/1) to obtain 248 mg of a yellow solid, yield 44%.

MS-ESI:m/z 456.0[M+H]+MS-ESI: m/z 456.0[M+H] + ;

1H NMR(400MHz,CDCl3)δ16.33(s,1H),8.22(d,J=9.1Hz,1H),7.79(s,1H),7.58(d,J=8.2Hz,1H),7.23(d,J=8.5Hz,1H),7.01(dd,J=9.0,2.3Hz,1H),6.74(d,J=2.3Hz,1H),2.78(t,J=6.2Hz,2H),2.38(t,J=6.4Hz,2H),2.09–1.98(m,2H). 1 H NMR (400 MHz, CDCl 3 ) δ 16.33 (s, 1H), 8.22 (d, J=9.1 Hz, 1H), 7.79 (s, 1H), 7.58 (d, J=8.2 Hz, 1H), 7.23 (d, J=8.5Hz, 1H), 7.01 (dd, J=9.0, 2.3Hz, 1H), 6.74 (d, J=2.3Hz, 1H), 2.78 (t, J=6.2Hz, 2H), 2.38 (t, J=6.4Hz, 2H), 2.09–1.98 (m, 2H).

实施例2(5-(2-氯-4-(三氟甲基)苯氧基)-2-硝基苯基)(5-羟基-1,3-二甲基-1H-吡唑-4-基)甲酮Example 2 (5-(2-Chloro-4-(trifluoromethyl)phenoxy)-2-nitrophenyl)(5-hydroxy-1,3-dimethyl-1H-pyrazole-4 -yl) ketone

Figure BDA0002355877140000202
Figure BDA0002355877140000202

步骤1:1,3-二甲基-1H-吡唑-5-基5-(2-氯-4-(三氟甲基)苯氧基)-2-硝基苯甲酸酯的合成Step 1: Synthesis of 1,3-Dimethyl-1H-pyrazol-5-yl 5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoate

Figure BDA0002355877140000203
Figure BDA0002355877140000203

将1,3-二甲基-5-羟基吡唑(425mg,3.78mmol)溶于超干二氯甲烷(20mL),然后向反应液中加入三乙胺(639mg,6.31mmol),-5℃下冷却,10min后,向该反应液中加入5-(2-氯-4-(三氟甲基)苯氧基)-2-硝基苯甲酰氯(1200mg,3.16mmol)的二氯甲烷(20mL)溶液,室温反应4h,TLC监测原料反应完。向反应液中加入饱和碳酸氢钠溶液(100mL),二氯甲烷萃取(50mL×3),合并有机相,无水Na2SO4干燥,过滤,二氯甲烷(20mL)洗涤滤饼,柱层析分离(洗脱剂:PE/EtOAc(v/v)=20/4),得到黄色油状液体1.19g,收率83%。Dissolve 1,3-dimethyl-5-hydroxypyrazole (425 mg, 3.78 mmol) in ultra-dry dichloromethane (20 mL), then add triethylamine (639 mg, 6.31 mmol) to the reaction solution, at -5°C After 10 min, 5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoyl chloride (1200 mg, 3.16 mmol) in dichloromethane ( 20mL) solution, reacted at room temperature for 4h, and TLC monitored the reaction of the raw materials. Saturated sodium bicarbonate solution (100 mL) was added to the reaction solution, extracted with dichloromethane (50 mL×3), the organic phases were combined, dried over anhydrous Na 2 SO 4 , filtered, the filter cake was washed with dichloromethane (20 mL), and the column layer was Separation (eluent: PE/EtOAc (v/v)=20/4) gave 1.19 g of a yellow oily liquid with a yield of 83%.

MS-ESI:m/z 456.0[M+H]+.MS-ESI: m/z 456.0[M+H] + .

步骤2:(5-(2-氯-4-(三氟甲基)苯氧基)-2-硝基苯基)(5-羟基-1,3-二甲基-1H-吡唑-4-基)甲酮的合成Step 2: (5-(2-Chloro-4-(trifluoromethyl)phenoxy)-2-nitrophenyl)(5-hydroxy-1,3-dimethyl-1H-pyrazole-4 Synthesis of -yl)methanone

Figure BDA0002355877140000204
Figure BDA0002355877140000204

将1,3-二甲基-1H-吡唑-5-基5-(2-氯-4-(三氟甲基)苯氧基)-2-硝基苯甲酸酯(1190mg,2.61mmol)溶于超干乙腈(30mL),然后向反应液中加入三乙胺(528mg,5.22mmol),最后向该反应液中加入三甲基氰硅烷(24mg,0.24mmol),室温反应。12h后TLC监测原料反应完。将反应减压蒸馏除去溶剂,用二氯甲烷萃取(50mL×3),水洗(50mL),合并有机相,无水Na2SO4干燥,过滤,二氯甲烷洗涤(10mL),柱层析分离(洗脱剂:DCM/MeOH(v/v)=100/1),得到粉色固体180mg,收率15%。1,3-Dimethyl-1H-pyrazol-5-yl 5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoate (1190 mg, 2.61 mmol) ) was dissolved in ultra-dry acetonitrile (30 mL), then triethylamine (528 mg, 5.22 mmol) was added to the reaction solution, and finally trimethylsilyl cyanide (24 mg, 0.24 mmol) was added to the reaction solution, and the reaction was carried out at room temperature. After 12h, the reaction of the starting materials was monitored by TLC. The reaction was evaporated under reduced pressure to remove the solvent, extracted with dichloromethane (50 mL×3), washed with water (50 mL), combined the organic phases, dried over anhydrous Na 2 SO 4 , filtered, washed with dichloromethane (10 mL), and separated by column chromatography (eluent: DCM/MeOH (v/v)=100/1) to obtain 180 mg of a pink solid in a yield of 15%.

MS-ESI:m/z 456.0[M+H]+MS-ESI: m/z 456.0[M+H] + ;

1H NMR(400MHz,CDCl3)δ8.28(d,J=9.1Hz,1H),7.81(s,1H),7.63(d,J=8.4Hz,1H),7.29(d,J=8.5Hz,1H),7.13(dd,J=9.1,2.6Hz,1H),6.81(d,J=2.6Hz,1H),3.63(s,3H),1.71(s,3H). 1 H NMR (400 MHz, CDCl 3 ) δ 8.28 (d, J=9.1 Hz, 1H), 7.81 (s, 1H), 7.63 (d, J=8.4 Hz, 1H), 7.29 (d, J=8.5 Hz ,1H),7.13(dd,J=9.1,2.6Hz,1H),6.81(d,J=2.6Hz,1H),3.63(s,3H),1.71(s,3H).

参考实施例2的类似制备方法,可得到如下实施例的化合物。Referring to the similar preparation method of Example 2, the compounds of the following examples can be obtained.

实施例3(5-(2-氯-4-(三氟甲基)苯氧基)-2-硝基苯基)(3-环丙基-5-羟基-1-甲基-1H-吡唑-4-基)甲酮Example 3 (5-(2-Chloro-4-(trifluoromethyl)phenoxy)-2-nitrophenyl)(3-cyclopropyl-5-hydroxy-1-methyl-1H-pyridine oxazol-4-yl)methanone

Figure BDA0002355877140000211
Figure BDA0002355877140000211

MS-ESI:m/z 482.1[M+H]+.MS-ESI: m/z 482.1[M+H] + .

1H NMR(400MHz,CDCl3)δ8.26(s,1H),7.80(s,1H),7.62(d,J=7.6Hz,1H),7.27(s,1H),7.14–7.02(m,1H),6.91(s,1H),3.57(s,3H),0.88(s,1H),0.71(s,2H),0.45(s,2H). 1 H NMR (400MHz, CDCl 3 ) δ 8.26(s, 1H), 7.80(s, 1H), 7.62(d, J=7.6Hz, 1H), 7.27(s, 1H), 7.14-7.02(m, 1H), 6.91(s, 1H), 3.57(s, 3H), 0.88(s, 1H), 0.71(s, 2H), 0.45(s, 2H).

实施例4(5-(2-氯-4-(三氟甲基)苯氧基)-2-硝基苯基)(5-羟基-1-甲基-1H-吡唑-4-基)甲酮Example 4 (5-(2-Chloro-4-(trifluoromethyl)phenoxy)-2-nitrophenyl)(5-hydroxy-1-methyl-1H-pyrazol-4-yl) ketone

Figure BDA0002355877140000212
Figure BDA0002355877140000212

MS-ESI:m/z 442.0[M+H]+MS-ESI: m/z 442.0 [M+H] + ;

1H NMR(400MHz,CDCl3)δ8.19(d,J=9.1Hz,1H),7.81(s,1H),7.62(d,J=8.5Hz,1H),7.29(d,J=8.5Hz,1H),7.24(s,1H),7.11(dd,J=9.1,2.7Hz,1H),6.96(d,J=2.7Hz,1H),3.70(s,3H). 1 H NMR (400 MHz, CDCl 3 ) δ 8.19 (d, J=9.1 Hz, 1H), 7.81 (s, 1H), 7.62 (d, J=8.5 Hz, 1H), 7.29 (d, J=8.5 Hz ,1H),7.24(s,1H),7.11(dd,J=9.1,2.7Hz,1H),6.96(d,J=2.7Hz,1H),3.70(s,3H).

实施例5(5-(2-氯-4-(三氟甲基)苯氧基)-2-硝基苯基)(5-羟基-1-乙基-1H-吡唑-4-基)甲酮Example 5 (5-(2-Chloro-4-(trifluoromethyl)phenoxy)-2-nitrophenyl)(5-hydroxy-1-ethyl-1H-pyrazol-4-yl) ketone

Figure BDA0002355877140000213
Figure BDA0002355877140000213

MS-ESI:m/z 456.0[M+H]+MS-ESI: m/z 456.0[M+H] + ;

1H NMR(400MHz,CDCl3)δ8.19(d,J=9.0Hz,1H),7.81(s,1H),7.62(d,J=8.5Hz,1H),7.28(d,J=8.6Hz,1H),7.25(s,1H),7.11(dd,J=9.0,2.7Hz,1H),6.97(d,J=2.7Hz,1H),4.06(q,J=7.3Hz,2H),1.45(t,J=7.3Hz,3H). 1 H NMR (400 MHz, CDCl 3 ) δ 8.19 (d, J=9.0 Hz, 1H), 7.81 (s, 1H), 7.62 (d, J=8.5 Hz, 1H), 7.28 (d, J=8.6 Hz) ,1H),7.25(s,1H),7.11(dd,J=9.0,2.7Hz,1H),6.97(d,J=2.7Hz,1H),4.06(q,J=7.3Hz,2H),1.45 (t,J=7.3Hz,3H).

实施例6(3-(2,6-二甲基苯氧基)-2-硝基苯基)(5-羟基-1,3-二甲基-1H-吡唑-4-基)甲酮Example 6 (3-(2,6-Dimethylphenoxy)-2-nitrophenyl)(5-hydroxy-1,3-dimethyl-1H-pyrazol-4-yl)methanone

Figure BDA0002355877140000221
Figure BDA0002355877140000221

MS-ESI:m/z 382.1[M+H]+MS-ESI: m/z 382.1 [M+H] + ;

1H NMR(400MHz,CDCl3)δ7.39(t,J=8.0Hz,1H),7.13(s,3H),7.05(d,J=7.6Hz,1H),6.66(d,J=8.4Hz,1H),3.64(s,3H),2.16(s,6H),1.92(s,3H). 1 H NMR (400 MHz, CDCl 3 ) δ 7.39 (t, J=8.0 Hz, 1H), 7.13 (s, 3H), 7.05 (d, J=7.6 Hz, 1H), 6.66 (d, J=8.4 Hz) ,1H),3.64(s,3H),2.16(s,6H),1.92(s,3H).

实施例7(3-(2-氯-4-(三氟甲基)苯氧基)-2-硝基苯基)(5-羟基-1,3-二甲基-1H-吡唑-4-基)甲酮Example 7 (3-(2-Chloro-4-(trifluoromethyl)phenoxy)-2-nitrophenyl)(5-hydroxy-1,3-dimethyl-1H-pyrazole-4 -yl) ketone

Figure BDA0002355877140000222
Figure BDA0002355877140000222

MS-ESI:m/z 456.1[M+H]+MS-ESI: m/z 456.1[M+H] + ;

1H NMR(400MHz,CDCl3)δ7.78(s,1H),7.58(t,J=7.9Hz,2H),7.28(s,1H),7.20(d,J=8.5Hz,1H),7.04(d,J=8.3Hz,1H),3.65(s,3H),1.94(s,3H). 1 H NMR (400MHz, CDCl 3 ) δ 7.78(s, 1H), 7.58(t, J=7.9Hz, 2H), 7.28(s, 1H), 7.20(d, J=8.5Hz, 1H), 7.04 (d, J=8.3Hz, 1H), 3.65(s, 3H), 1.94(s, 3H).

实施例8(3-(2-氯-4-(三氟甲基)苯氧基)-2-硝基苯基)(3-环丙基-5-羟基-1-甲基-1H-吡唑-4-基)甲酮Example 8 (3-(2-Chloro-4-(trifluoromethyl)phenoxy)-2-nitrophenyl)(3-cyclopropyl-5-hydroxy-1-methyl-1H-pyridine oxazol-4-yl)methanone

Figure BDA0002355877140000223
Figure BDA0002355877140000223

MS-ESI:m/z 482.1[M+H]+MS-ESI: m/z 482.1[M+H] + ;

1H NMR(400MHz,CDCl3)δ7.80(s,1H),7.58(t,J=7.9Hz,2H),7.47(d,J=7.6Hz,1H),7.21(d,J=8.5Hz,1H),7.05(d,J=8.3Hz,1H),3.64(s,3H),1.32(dd,J=9.2,4.1Hz,1H),0.94–0.88(m,2H),0.67–0.60(m,2H). 1 H NMR (400 MHz, CDCl 3 ) δ 7.80 (s, 1H), 7.58 (t, J=7.9 Hz, 2H), 7.47 (d, J=7.6 Hz, 1H), 7.21 (d, J=8.5 Hz ,1H),7.05(d,J=8.3Hz,1H),3.64(s,3H),1.32(dd,J=9.2,4.1Hz,1H),0.94–0.88(m,2H),0.67–0.60( m, 2H).

实施例9(5-(2,4-二氯苯氧基)-2-硝基苯基)(5-羟基-1,3-二甲基-1H-吡唑-4-基)甲酮Example 9 (5-(2,4-Dichlorophenoxy)-2-nitrophenyl)(5-hydroxy-1,3-dimethyl-1H-pyrazol-4-yl)methanone

Figure BDA0002355877140000224
Figure BDA0002355877140000224

MS-ESI:m/z 422.0[M+H]+MS-ESI: m/z 422.0[M+H] + ;

1H NMR(400MHz,CDCl3)δ8.27(d,J=9.1Hz,1H),7.55(d,J=2.3Hz,1H),7.36(dd,J=8.6,2.3Hz,1H),7.21–7.07(m,2H),6.76(d,J=2.6Hz,1H),3.64(s,3H),1.71(s,3H). 1 H NMR (400 MHz, CDCl 3 ) δ 8.27 (d, J=9.1 Hz, 1H), 7.55 (d, J=2.3 Hz, 1H), 7.36 (dd, J=8.6, 2.3 Hz, 1H), 7.21 –7.07(m, 2H), 6.76(d, J=2.6Hz, 1H), 3.64(s, 3H), 1.71(s, 3H).

实施例10(5-(2,4-二氯苯氧基)-2-硝基苯基)(5-羟基-1-甲基-1H-吡唑-4-基)甲酮Example 10 (5-(2,4-Dichlorophenoxy)-2-nitrophenyl)(5-hydroxy-1-methyl-1H-pyrazol-4-yl)methanone

Figure BDA0002355877140000225
Figure BDA0002355877140000225

MS-ESI:m/z 409.9[M+H]+MS-ESI: m/z 409.9 [M+H] + ;

1H NMR(400MHz,CDCl3)δ8.18(d,J=9.1Hz,1H),7.55(d,J=2.4Hz,1H),7.36(dd,J=8.6,2.4Hz,1H),7.28(s,1H),7.16(d,J=8.7Hz,1H),7.09(dd,J=9.1,2.7Hz,1H),6.91(d,J=2.7Hz,1H),3.72(s,3H). 1 H NMR (400 MHz, CDCl 3 ) δ 8.18 (d, J=9.1 Hz, 1H), 7.55 (d, J=2.4 Hz, 1H), 7.36 (dd, J=8.6, 2.4 Hz, 1H), 7.28 (s, 1H), 7.16 (d, J=8.7Hz, 1H), 7.09 (dd, J=9.1, 2.7Hz, 1H), 6.91 (d, J=2.7Hz, 1H), 3.72 (s, 3H) .

实施例11(3-(4-氯苯氧基)-2-硝基苯基)(5-羟基-1,3-二甲基-1H-吡唑-4-基)甲酮Example 11 (3-(4-Chlorophenoxy)-2-nitrophenyl)(5-hydroxy-1,3-dimethyl-1H-pyrazol-4-yl)methanone

Figure BDA0002355877140000231
Figure BDA0002355877140000231

MS-ESI:m/z 388.0[M+H]+.MS-ESI: m/z 388.0[M+H] + .

实施例12(3-(4-氯苯氧基)-2-硝基苯基)(1-乙基-5-羟基-1H-吡唑-4-基)甲酮Example 12 (3-(4-Chlorophenoxy)-2-nitrophenyl)(1-ethyl-5-hydroxy-1H-pyrazol-4-yl)methanone

Figure BDA0002355877140000232
Figure BDA0002355877140000232

MS-ESI:m/z 388.0[M+H]+.MS-ESI: m/z 388.0[M+H] + .

1H NMR(400MHz,CDCl3)δ7.63–7.44(m,3H),7.36(d,J=7.2Hz,2H),7.19–6.96(m,3H),4.08(d,J=7.2Hz,2H),1.46(t,J=6.6Hz,3H). 1 H NMR (400 MHz, CDCl 3 ) δ 7.63-7.44 (m, 3H), 7.36 (d, J=7.2 Hz, 2H), 7.19-6.96 (m, 3H), 4.08 (d, J=7.2 Hz, 2H),1.46(t,J=6.6Hz,3H).

实施例13(3-(2,4-二氯苯氧基)-2-硝基苯基)(5-羟基-1,3-二甲基-1H-吡唑-4-基)甲酮Example 13 (3-(2,4-Dichlorophenoxy)-2-nitrophenyl)(5-hydroxy-1,3-dimethyl-1H-pyrazol-4-yl)methanone

Figure BDA0002355877140000233
Figure BDA0002355877140000233

MS-ESI:m/z 422.1[M+H]+.MS-ESI: m/z 422.1[M+H] + .

实施例14(3-(2-氯-4-(三氟甲基)苯氧基)-4-硝基苯基)(5-羟基-1,3-二甲基-1H-吡唑-4-基)甲酮Example 14 (3-(2-Chloro-4-(trifluoromethyl)phenoxy)-4-nitrophenyl)(5-hydroxy-1,3-dimethyl-1H-pyrazole-4 -yl) ketone

Figure BDA0002355877140000234
Figure BDA0002355877140000234

MS-ESI:m/z 456.0[M+H]+.MS-ESI: m/z 456.0[M+H] + .

参考实施例1的类似制备方法,可得到如下实施例的化合物。Referring to the similar preparation method of Example 1, the compounds of the following examples can be obtained.

实施例15 2-(3-(2,6-二甲基苯氧基)-2-硝基苯甲酰基)-3-羟基环己-2-烯酮Example 15 2-(3-(2,6-dimethylphenoxy)-2-nitrobenzoyl)-3-hydroxycyclohex-2-enone

Figure BDA0002355877140000235
Figure BDA0002355877140000235

MS-ESI:m/z 382.1[M+H]+MS-ESI: m/z 382.1 [M+H] + ;

1H NMR(400MHz,CDCl3)δ7.33(t,J=8.0Hz,1H),7.11(s,3H),6.85(d,J=7.6Hz,1H),6.60(d,J=8.4Hz,1H),2.78(s,2H),2.45(s,2H),2.18(s,6H),2.10–2.01(m,2H). 1 H NMR (400 MHz, CDCl 3 ) δ 7.33 (t, J=8.0 Hz, 1H), 7.11 (s, 3H), 6.85 (d, J=7.6 Hz, 1H), 6.60 (d, J=8.4 Hz , 1H), 2.78(s, 2H), 2.45(s, 2H), 2.18(s, 6H), 2.10–2.01(m, 2H).

实施例16 3-羟基-2-(3-(4-甲氧基苯氧基)-2-硝基苯甲酰基)环己-2-烯酮Example 16 3-Hydroxy-2-(3-(4-methoxyphenoxy)-2-nitrobenzoyl)cyclohex-2-enone

Figure BDA0002355877140000236
Figure BDA0002355877140000236

MS-ESI:m/z 384.1[M+H]+MS-ESI: m/z 384.1 [M+H] + ;

1H NMR(400MHz,CDCl3)δ7.41(t,J=8.0Hz,1H),7.06(d,J=9.2Hz,2H),6.95(d,J=8.8Hz,1H),6.92(d,J=8.8Hz,3H),3.81(s,3H),2.78(t,J=6.4Hz,2H),2.44(t,J=6.4Hz,2H),2.09–2.00(m,2H). 1 H NMR (400 MHz, CDCl 3 ) δ 7.41 (t, J=8.0 Hz, 1H), 7.06 (d, J=9.2 Hz, 2H), 6.95 (d, J=8.8 Hz, 1H), 6.92 (d , J=8.8Hz, 3H), 3.81(s, 3H), 2.78(t, J=6.4Hz, 2H), 2.44(t, J=6.4Hz, 2H), 2.09–2.00(m, 2H).

实施例17 2-(3-(2,4-二氯苯氧基)-4-硝基苯甲酰基)-3-羟基环己-2-烯酮Example 17 2-(3-(2,4-Dichlorophenoxy)-4-nitrobenzoyl)-3-hydroxycyclohex-2-enone

Figure BDA0002355877140000241
Figure BDA0002355877140000241

MS-ESI:m/z 422.0[M+H]+MS-ESI: m/z 422.0[M+H] + ;

1H NMR(400MHz,CDCl3)δ16.49(s,1H),8.00(d,J=8.4Hz,1H),7.51(d,J=2.4Hz,1H),7.28(td,J=8.4,2.0Hz,2H),7.06(d,J=8.7Hz,1H),6.96(d,J=1.4Hz,1H),2.78(s,2H),2.46(s,2H),2.24–1.98(m,2H). 1 H NMR (400 MHz, CDCl 3 ) δ 16.49 (s, 1H), 8.00 (d, J=8.4 Hz, 1H), 7.51 (d, J=2.4 Hz, 1H), 7.28 (td, J=8.4, 2.0Hz, 2H), 7.06(d, J=8.7Hz, 1H), 6.96(d, J=1.4Hz, 1H), 2.78(s, 2H), 2.46(s, 2H), 2.24–1.98(m, 2H).

实施例18 2-(5-(2,4-二氯苯氧基)-2-硝基苯甲酰基)3-羟基环己-2-烯酮Example 18 2-(5-(2,4-Dichlorophenoxy)-2-nitrobenzoyl)3-hydroxycyclohex-2-enone

Figure BDA0002355877140000242
Figure BDA0002355877140000242

MS-ESI:m/z 422.0[M+H]+MS-ESI: m/z 422.0[M+H] + ;

1H NMR(400MHz,CDCl3)δ16.37(s,1H),8.21(d,J=9.1Hz,1H),7.54(d,J=2.4Hz,1H),7.45–7.29(m,1H),7.08(t,J=28.2Hz,1H),6.95(dt,J=21.5,10.7Hz,1H),6.69(d,J=2.7Hz,1H),2.80(t,J=6.2Hz,2H),2.39(t,J=6.5Hz,2H),2.14–1.98(m,2H). 1 H NMR (400 MHz, CDCl 3 ) δ 16.37 (s, 1H), 8.21 (d, J=9.1 Hz, 1H), 7.54 (d, J=2.4 Hz, 1H), 7.45-7.29 (m, 1H) ,7.08(t,J=28.2Hz,1H),6.95(dt,J=21.5,10.7Hz,1H),6.69(d,J=2.7Hz,1H),2.80(t,J=6.2Hz,2H) ,2.39(t,J=6.5Hz,2H),2.14–1.98(m,2H).

实施例19 2-(3-(4-氯苯氧基)-2-硝基苯甲酰基)-3-羟基环己-2-烯酮Example 19 2-(3-(4-Chlorophenoxy)-2-nitrobenzoyl)-3-hydroxycyclohex-2-enone

Figure BDA0002355877140000243
Figure BDA0002355877140000243

MS-ESI:m/z 388.0[M+H]+.MS-ESI: m/z 388.0[M+H] + .

实施例20 2-(3-(2,4-二氯苯氧基)-2-硝基苯甲酰基)-3-羟基环己-2-烯酮Example 20 2-(3-(2,4-Dichlorophenoxy)-2-nitrobenzoyl)-3-hydroxycyclohex-2-enone

Figure BDA0002355877140000244
Figure BDA0002355877140000244

MS-ESI:m/z 422.1[M+H]+.MS-ESI: m/z 422.1[M+H] + .

实施例21 3-(5-(2-氯-4-(三氟甲基)苯氧基)-2-硝基苯甲酰基)-4-羟基双环[3.2.1]辛-3-烯-2-酮Example 21 3-(5-(2-Chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoyl)-4-hydroxybicyclo[3.2.1]oct-3-ene- 2-keto

Figure BDA0002355877140000245
Figure BDA0002355877140000245

MS-ESI:m/z 482.1[M+H]+.MS-ESI: m/z 482.1[M+H] + .

1H NMR(400MHz,CDCl3)δ8.22(d,J=9.2Hz,1H),7.81(d,J=2.0Hz,1H),7.60(dd,J=8.4,2.0Hz,1H),7.26(d,J=8.8Hz,1H),7.03(dd,J=9.2,2.8Hz,1H),6.80(d,J=2.8Hz,1H),2.20(d,J=12.0Hz,2H),2.10(d,J=37.6Hz,2H),1.77–1.66(m,2H),1.67–1.57(m,2H). 1 H NMR (400MHz, CDCl 3 ) δ 8.22 (d, J=9.2Hz, 1H), 7.81 (d, J=2.0Hz, 1H), 7.60 (dd, J=8.4, 2.0Hz, 1H), 7.26 (d, J=8.8Hz, 1H), 7.03 (dd, J=9.2, 2.8Hz, 1H), 6.80 (d, J=2.8Hz, 1H), 2.20 (d, J=12.0Hz, 2H), 2.10 (d, J=37.6Hz, 2H), 1.77–1.66 (m, 2H), 1.67–1.57 (m, 2H).

实施例22 2-(3-(2-氯-4-(三氟甲基)苯氧基)-2-硝基苯甲酰基)-3-羟基环己-2-烯酮Example 22 2-(3-(2-Chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoyl)-3-hydroxycyclohex-2-enone

Figure BDA0002355877140000251
Figure BDA0002355877140000251

MS-ESI:m/z 456.0[M+H]+.MS-ESI: m/z 456.0[M+H] + .

1H NMR(400MHz,CDCl3)δ16.43(s,1H),7.78(s,1H),7.60(d,J=8.0Hz,1H),7.58–7.49(m,1H),7.19–7.12(m,2H),7.09(d,J=8.4Hz,1H),2.81(s,2H),2.45(s,2H),2.07(p,J=6.4Hz,2H). 1 H NMR (400 MHz, CDCl 3 ) δ 16.43 (s, 1H), 7.78 (s, 1H), 7.60 (d, J=8.0 Hz, 1H), 7.58–7.49 (m, 1H), 7.19–7.12 ( m, 2H), 7.09(d, J=8.4Hz, 1H), 2.81(s, 2H), 2.45(s, 2H), 2.07(p, J=6.4Hz, 2H).

实施例23 2-(3-(2-氯-4-(三氟甲基)苯氧基)-4-硝基苯甲酰基)-3-羟基环己-2-烯酮Example 23 2-(3-(2-Chloro-4-(trifluoromethyl)phenoxy)-4-nitrobenzoyl)-3-hydroxycyclohex-2-enone

Figure BDA0002355877140000252
Figure BDA0002355877140000252

MS-ESI:m/z 456.0[M+H]+.MS-ESI: m/z 456.0[M+H] + .

分别参考实施例1和2的类似制备方法,可得到如下对比例的化合物。Referring to the similar preparation methods of Examples 1 and 2, respectively, the compounds of the following comparative examples can be obtained.

对比例1 3-羟基-2-(3-苯氧基苯甲酰基)环己-2-烯酮Comparative Example 1 3-Hydroxy-2-(3-phenoxybenzoyl)cyclohex-2-enone

Figure BDA0002355877140000253
Figure BDA0002355877140000253

MS-ESI:m/z 309.1[M+H]+.MS-ESI: m/z 309.1[M+H] + .

对比例2(5-羟基-1,3-二甲基-1H-吡唑-4-基)(3-苯氧基苯基)甲酮Comparative example 2(5-hydroxy-1,3-dimethyl-1H-pyrazol-4-yl)(3-phenoxyphenyl)methanone

Figure BDA0002355877140000254
Figure BDA0002355877140000254

MS-ESI:m/z 309.1[M+H]+.MS-ESI: m/z 309.1[M+H] + .

1H NMR(400MHz,CDCl3)δ7.41(t,J=7.6Hz,1H),7.34(t,J=7.6Hz,2H),7.27(d,J=4.8Hz,1H),7.20–7.08(m,3H),7.02(d,J=7.8Hz,2H),3.58(s,3H),1.96(s,3H). 1 H NMR (400 MHz, CDCl 3 ) δ 7.41 (t, J=7.6 Hz, 1H), 7.34 (t, J=7.6 Hz, 2H), 7.27 (d, J=4.8 Hz, 1H), 7.20-7.08 (m, 3H), 7.02(d, J=7.8Hz, 2H), 3.58(s, 3H), 1.96(s, 3H).

生物实施例biological example

化合物配制:用分析天平(0.0001g)称取一定质量的原药,用适量DMF溶解,然后用一定体积的含1‰吐温-80乳化剂蒸馏水稀释备用。Compound preparation: Weigh a certain quality of the original drug with an analytical balance (0.0001g), dissolve it with an appropriate amount of DMF, and then dilute it with a certain volume of distilled water containing 1‰ Tween-80 emulsifier for use.

试验方法:供试靶标为苘麻、马齿苋、稗草、百日草。Test method: The test targets were Abalone, purslane, barnyardgrass and zinnia.

茎叶喷雾法:取长宽均7.0cm花盆,装土至3/4处,直接播种预处理的杂草靶标种子,覆土约1.0cm,待幼苗长至适龄阶段进行喷雾处理。各化合物按照设定剂量施药后,移入室外培养,21天后调查对杂草的活性(%)。Stem and leaf spray method: Take a flowerpot with a length and width of 7.0cm, fill it with soil to 3/4, directly sow the pretreated weed target seeds, cover the soil with about 1.0cm, and spray the seedlings when they grow to the appropriate age. After each compound was applied at the set dose, it was transferred to the outside for cultivation, and the activity (%) against weeds was investigated after 21 days.

试验结果示于表A至表D中。The test results are shown in Tables A to D.

表A剂量为300g a.i./ha,本发明化合物对马齿苋的防效Table A The dose is 300g a.i./ha, the control effect of the compound of the present invention on purslane

Figure BDA0002355877140000261
Figure BDA0002355877140000261

表A结果显示,本发明化合物在300g a.i./ha对马齿苋具有优异的防治效果。另外,本发明化合物在300g a.i./ha对苘麻、稗草、百日草亦具有较好的防效,例如实施例1对苘麻的防效为98%;实施例21对百日草的防效为85%;实施例22对稗草的防效为80%。The results in Table A show that the compound of the present invention has an excellent control effect on purslane at 300 g a.i./ha. In addition, at 300 g a.i./ha, the compound of the present invention also has a good control effect on abalone, barnyardgrass and zinnia, for example, the control effect of Example 1 on abalone is 98%; The control effect is 85%; the control effect of Example 22 on barnyardgrass is 80%.

表B剂量为150g a.i./ha,本发明化合物对马齿苋的防效Table B The dose is 150 g a.i./ha, the control effect of the compound of the present invention on purslane

Figure BDA0002355877140000262
Figure BDA0002355877140000262

表C剂量为150g a.i./ha,本发明化合物对百日草的防效Table C The dose is 150 g a.i./ha, the control effect of the compound of the present invention on zinnia

Figure BDA0002355877140000263
Figure BDA0002355877140000263

表B和表C结果显示,本发明化合物在150g a.i./ha对马齿苋和百日草具有优异的防治效果。另外,本发明化合物在150g a.i./ha对苘麻和稗草亦具有较好的防效,例如实施例1对苘麻的防效为98%;实施例21对稗草的防效为82%;实施例22对稗草的防效为85%。The results in Tables B and C show that the compounds of the present invention have excellent control effects on purslane and zinnia at 150 g a.i./ha. In addition, the compound of the present invention also has a good control effect on abalone and barnyard grass at 150 g a.i./ha. For example, the control effect of Example 1 on abalone is 98%; the control effect of Example 21 on barnyard grass is 82%. ; The control effect of Example 22 on barnyardgrass is 85%.

表D剂量为75、37.5或18.75g a.i./ha,本发明化合物对马齿苋的防效Table D Control efficacy of compounds of the present invention against purslane at doses of 75, 37.5 or 18.75 g a.i./ha

Figure BDA0002355877140000264
Figure BDA0002355877140000264

表D结果显示,本发明化合物在低剂量下对马齿苋仍具有优异的防治效果。The results in Table D show that the compounds of the present invention still have excellent control effects on purslane at low doses.

本发明化合物对阔叶科杂草(如苘麻、反枝苋、鱧肠和马齿苋)和禾本科杂草(如马唐、稗草、黑麦草和狗尾草)均具有很好的防治效果。对作物安全,药效发挥快,而且对杂草的防治效果优于市售除草剂和结构近似的苯甲酰类化合物,具有很好的应用前景。The compound of the present invention has good control effect on broad-leaved weeds (such as amaranth, amaranth, snakehead and purslane) and grass weeds (such as crabgrass, barnyardgrass, ryegrass and foxtail) . It is safe to crops, has fast drug effect, and has better control effect on weeds than commercial herbicides and benzoyl compounds with similar structures, and has a good application prospect.

Claims (10)

1. A compound which is a compound of formula (I) or a stereoisomer, tautomer, nitroxide or salt of a compound of formula (I):
Figure FDA0002355877130000011
wherein:
R1、R2、R3、R4and R5Each independently is hydrogen, halogen, cyano, hydroxy, nitro, amino, carboxyl, C1-8Alkyl radical, C2-8Alkenyl radical, C2-8Alkynyl, halo C1-8Alkyl, halo C2-8Alkenyl, halo C2-8Alkynyl, C1-8Alkoxy, halo C1-8Alkoxy radical, C1-8Alkylthio radical, C1-8Alkylamino radical, C3-10Cycloalkyl radical, C2-12Heterocyclic group, C6-14Aryl radical, C1-9Heteroaryl group, C3-10Cycloalkyl radical C1-8Alkyl radical, C2-12Heterocyclyl radical C1-8Alkyl radical, C6-14Aryl radical C1-8Alkyl radical, C1-9Heteroaryl C1-8Alkyl radical, C3-10Cycloalkyl oxy, C2-12Heterocyclyloxy, C6-14Aryloxy radical or C1-9A heteroaryloxy group;
q is the following subformula:
Figure FDA0002355877130000012
Raand RbEach independently is hydrogen, C1-8Alkyl or C3-8A cycloalkyl group;
R1、R2、R3、R4、R5、Raand RbEach independently is optionally selected from R by 1,2,3, 4, 5 or 6cSubstituted with the substituent(s);
each RcIndependently fluorine, chlorine, bromine, iodine, amino, nitro, cyano, hydroxy, carboxyl, C1-6Alkyl, halo C1-6Alkyl radical, C2-6Alkenyl, halo C2-6Alkenyl radical, C2-6Alkynyl, halo C2-6Alkynyl, C1-6Alkoxy, halo C1-6Alkoxy radical, C1-6Alkylamino radical, C1-6Alkylthio, halo C1-6Alkylamino, halogeno C1-6Alkylthio radical, C6-10Aryl radical, C6-10Aryloxy radical, C1-6Heteroaryl or C1-6A heteroaryloxy group.
2. The compound of claim 1, wherein
R1、R2、R3、R4And R5Each independently is hydrogen, halogen, cyano, hydroxy, nitro, amino, carboxyl, C1-6Alkyl radical, C2-6Alkenyl radical, C2-6Alkynyl, halo C1-6Alkyl, halo C2-6Alkenyl, halo C2-6Alkynyl, C1-6Alkoxy, halo C1-6Alkoxy radical, C1-6Alkylthio radical, C1-6Alkylamino radical, C3-8Cycloalkyl radical, C2-8Heterocyclic group, C6-10Aryl radical, C1-6Heteroaryl group, C3-8Cycloalkyl radical C1-6Alkyl radical, C2-8Heterocyclyl radical C1-6Alkyl radical, C6-10Aryl radical C1-6Alkyl radical, C1-6Heteroaryl C1-6Alkyl radical, C3-8Cycloalkyl oxy, C2-8Heterocyclyloxy, C6-10Aryloxy radical or C1-6A heteroaryloxy group;
R1、R2、R3、R4and R5Each independently is optionally selected from R by 1,2,3, 4, 5 or 6cSubstituted with the substituent(s);
each RcIndependently fluorine, chlorine, bromine, iodine, amino, nitro, cyano, hydroxy, carboxyl, C1-4Alkyl, halo C1-4Alkyl radical, C2-4Alkenyl, halo C2-4Alkenyl radical, C2-4Alkynyl, halo C2-4Alkynyl, C1-4Alkoxy, halo C1-4Alkoxy radical, C1-4Alkylamino radical, C1-4Alkylthio, halo C1-4Alkylamino, halogeno C1-4Alkylthio radical, C6-10Aryl radical, C6-10Aryloxy radical, C1-6Heteroaryl or C1-6A heteroaryloxy group.
3. The compound of claim 2, wherein
R1、R2、R3、R4And R5Each independently is hydrogen, halogen, cyano, hydroxy, nitro, amino, carboxyl, C1-4Alkyl radical, C2-4Alkenyl radical, C2-4Alkynyl, halo C1-4Alkyl, halo C2-4Alkenyl, halo C2-4Alkynyl, C1-4Alkoxy, halo C1-4Alkoxy radical, C1-4Alkylthio radical, C1-4Alkylamino radical, C3-6Cycloalkyl radical, C2-6Heterocyclic group, C6-10Aryl radical, C1-5Heteroaryl group, C3-6Cycloalkyl radical C1-3Alkyl radical, C2-6Heterocyclyl radical C1-3Alkyl radical, C6-10Aryl radical C1-3Alkyl radical, C1-5Heteroaryl C1-3Alkyl radical, C3-6Cycloalkyl oxy, C2-6Heterocyclyloxy, C6-10Aryloxy radical or C1-5A heteroaryloxy group;
R1、R2、R3、R4and R5Each independently is optionally selected from R by 1,2,3, 4, 5 or 6cSubstituted with the substituent(s);
each RcIndependently fluorine, chlorine, bromine, iodine, amino, nitro, cyano, hydroxyCarboxy, methyl, ethyl, n-propyl, isopropyl, difluoromethyl, trifluoromethyl, methoxy or trifluoromethoxy.
4. The compound of claim 1, wherein
RaAnd RbEach independently is hydrogen, C1-6Alkyl or C3-8A cycloalkyl group.
5. The compound of claim 4, wherein
RaAnd RbEach independently is hydrogen, C1-4Alkyl or C3-6A cycloalkyl group.
6. The compound according to any one of claims 1 to 5, which is a compound of formula (Ia) or a stereoisomer, tautomer, nitroxide or salt of a compound of formula (Ia):
Figure FDA0002355877130000021
or, it is a compound of formula (Ib) or a stereoisomer, tautomer, nitroxide or salt of a compound of formula (Ib):
Figure FDA0002355877130000022
or, it is a compound of formula (Ic) or a stereoisomer, tautomer, nitroxide or salt of a compound of formula (Ic):
Figure FDA0002355877130000023
7. the compound of claim 6, wherein
Q is the following subformula:
Figure FDA0002355877130000024
wherein R isaAnd RbEach independently hydrogen, methyl, ethyl or cyclopropyl;
R1、R2、R3、R4and R5Each independently hydrogen, halogen, cyano, hydroxy, nitro, amino, carboxy, methyl, ethyl, n-propyl, isopropyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, difluoromethoxy or trifluoromethoxy.
8. The compound according to any one of claims 1 to 7, which is a compound having one of the following structures or a stereoisomer, a tautomer, a nitroxide or a salt thereof of a compound having one of the following structures:
Figure FDA0002355877130000031
Figure FDA0002355877130000041
9. a composition comprising a compound of any one of claims 1-8.
10. Use of a compound according to any one of claims 1 to 8 or a composition according to claim 9 in agriculture.
CN202010007574.7A 2019-02-14 2020-01-04 Substituted benzoyl compounds and application thereof in agriculture Active CN111559965B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2019101139245 2019-02-14
CN201910113924 2019-02-14

Publications (2)

Publication Number Publication Date
CN111559965A true CN111559965A (en) 2020-08-21
CN111559965B CN111559965B (en) 2022-11-18

Family

ID=72067679

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010007574.7A Active CN111559965B (en) 2019-02-14 2020-01-04 Substituted benzoyl compounds and application thereof in agriculture

Country Status (1)

Country Link
CN (1) CN111559965B (en)

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4517010A (en) * 1980-02-01 1985-05-14 Rhone-Poulenc Inc. 2-Nitro-5(substituted-phenoxy) benzoyl derivatives as herbicides
WO1988004652A1 (en) * 1986-12-17 1988-06-30 Nippon Soda Co., Ltd. Heterocyclic compounds having triketo skeleton
CN1033457A (en) * 1987-06-08 1989-06-21 孟山都公司 Substituted 3-(4-nitrophenoxy)pyrazoles and their use as herbicides
US4889946A (en) * 1979-12-14 1989-12-26 Bayer Aktiengesellschaft Phenoxybenzoic acid compounds and herbicidal and plant growth regulant compositions
US5110343A (en) * 1987-11-28 1992-05-05 Nippon Soda Co., Ltd. Cyclohexenone derivatives
CN1077449A (en) * 1992-03-31 1993-10-20 赫彻斯特股份公司 2-benzoyl cyclohexanedione salt selective herbicide, preparation method and application thereof in weeding
US6156702A (en) * 1997-08-07 2000-12-05 Basf Aktiengesellschaft Substituted 4-benzoylpyrazoles
CN1306395A (en) * 1998-06-23 2001-08-01 阿温提斯作物科学有限公司 Combinations of herbicides and safeners
WO2001097614A1 (en) * 2000-06-19 2001-12-27 Bayer Cropscience Gmbh Herbicidal agents
CN1735608A (en) * 2003-01-09 2006-02-15 拜尔作物科学有限公司 Substituted benzoyl derivatives useful as herbicides
US20120322657A1 (en) * 1998-11-21 2012-12-20 Frank Ziemer Herbicide/safener combintions

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889946A (en) * 1979-12-14 1989-12-26 Bayer Aktiengesellschaft Phenoxybenzoic acid compounds and herbicidal and plant growth regulant compositions
US4517010A (en) * 1980-02-01 1985-05-14 Rhone-Poulenc Inc. 2-Nitro-5(substituted-phenoxy) benzoyl derivatives as herbicides
WO1988004652A1 (en) * 1986-12-17 1988-06-30 Nippon Soda Co., Ltd. Heterocyclic compounds having triketo skeleton
CN1033457A (en) * 1987-06-08 1989-06-21 孟山都公司 Substituted 3-(4-nitrophenoxy)pyrazoles and their use as herbicides
US5110343A (en) * 1987-11-28 1992-05-05 Nippon Soda Co., Ltd. Cyclohexenone derivatives
CN1077449A (en) * 1992-03-31 1993-10-20 赫彻斯特股份公司 2-benzoyl cyclohexanedione salt selective herbicide, preparation method and application thereof in weeding
US6156702A (en) * 1997-08-07 2000-12-05 Basf Aktiengesellschaft Substituted 4-benzoylpyrazoles
CN1306395A (en) * 1998-06-23 2001-08-01 阿温提斯作物科学有限公司 Combinations of herbicides and safeners
US20120322657A1 (en) * 1998-11-21 2012-12-20 Frank Ziemer Herbicide/safener combintions
WO2001097614A1 (en) * 2000-06-19 2001-12-27 Bayer Cropscience Gmbh Herbicidal agents
CN1735608A (en) * 2003-01-09 2006-02-15 拜尔作物科学有限公司 Substituted benzoyl derivatives useful as herbicides

Also Published As

Publication number Publication date
CN111559965B (en) 2022-11-18

Similar Documents

Publication Publication Date Title
CN110878058B (en) Isoxazoline derivatives and their use in agriculture
WO2019223664A1 (en) Oxazoline derivatives and uses in agriculture thereof
CN111566088B (en) Quinoline derivative and preparation method and application thereof
CN112409263B (en) Substituted benzoyl compounds and application thereof
CN112409226B (en) Substituted benzoyl compounds and application thereof
CN111574509B (en) Isoxazoline derivatives and their use in agriculture
CN114437056B (en) Pyridine diazonone compounds and their applications
CN114478506B (en) Pyridineoxazole compounds and their applications
CN112689626B (en) Substituted benzoyl-pyrazoles and their applications in agriculture
CN112300092B (en) Heterocyclylalkyl-substituted dichlorobenzoyl compounds and application thereof
CN114478507B (en) Pyrimidine oxazole compounds and their applications
CN112225707B (en) Isoxazoline derivatives and their use in agriculture
CN113527224B (en) Thiazole derivative and application thereof in agriculture
CN112174889B (en) Substituted benzoyl compounds and application thereof in agriculture
CN114507226A (en) Pyridine oxazole compound containing chlorine-fluorine substituent and application thereof
CN111943900B (en) Isoxazoline derivatives and their use in agriculture
CN112430220B (en) Substituted benzoyl compounds and application thereof
CN111559965A (en) Substituted benzoyl compounds and application thereof in agriculture
CN114380761A (en) Novel isoxazole derivative and application thereof in agriculture
CN114163400B (en) Cyclohexanedione-benzothiadiazine compounds and their applications
CN114163430A (en) Benzothiadiazine derivative and application thereof in agriculture
CN113620941B (en) Cyclopropyl-pyrazole derivatives and their use in agriculture
CN112142671B (en) Substituted benzoyl-pyrazoles and application thereof in agriculture
CN114163394A (en) Chloromethyl-containing isoxazoline derivatives and use thereof
CN114075149A (en) Difluorophenyl-containing heterocyclic compound and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant